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ABSTRACT 
 
 Regulatory light chain (RLC) phosphorylation in fast twitch muscle is catalyzed 
by skeletal myosin light chain kinase (skMLCK), a reaction known to increase muscle 
force, work, and power. The purpose of this study was to explore the contribution of RLC 
phosphorylation on the power of mouse fast muscle during high frequency (100 Hz) 
concentric contractions. To determine peak power shortening ramps (1.05 to 0.90 Lo) 
were applied to Wildtype (WT) and skMLCK knockout (skMLCK-/-) EDL muscles at a 
range of shortening velocities between 0.05-0.65 of maximal shortening velocity (Vmax), 
before and after a conditioning stimulus (CS). As a result, mean power was increased to 
1.28 ± 0.05 and 1.11 ± .05 of pre-CS values, when collapsed for shortening velocity in 
WT and skMLCK-/-, respectively (n = 10). In addition, fitting each data set to a second 
order polynomial revealed that WT mice had significantly higher peak power output 
(27.67 ± 1.12 W/ kg-1) than skMLCK-/- (25.97 ± 1.02 W/ kg-1), (p < .05). No significant 
differences in optimal velocity for peak power were found between conditions and 
genotypes (p > .05). Analysis with Urea Glycerol PAGE determined that RLC phosphate 
content had been elevated in WT muscles from 8 to 63 % while minimal changes were 
observed in skMLCK-/- muscles: 3 and 8 %, respectively. Therefore, the lack of 
stimulation induced increase in RLC phosphate content resulted in a ~40 % smaller 
enhancement of mean power in skMLCK-/-. The increase in power output in WT mice 
suggests that RLC phosphorylation is a major potentiating component required for 
achieving peak muscle performance during brief high frequency concentric contractions.  
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REVIEW OF LITERATURE 
1.1 Introduction 
Muscle contraction is a means to move or resist a given load by applying force, 
whether it is in the form of locomotion or moving an external object. The underlying 
trigger for movement is a series of motor signals carried through the central nervous 
system causing muscles to contract. Depending on the load, muscles will either contract 
by creating force without a change in length (isometrically), or dynamically, by creating 
force while lengthening (eccentrically) or shortening (concentrically). Isometric 
contractions are useful in many settings; however, they do not comprise a high portion of 
the contractions used during movement. In lieu of this, it is essential to our fundamental 
understanding of the musculoskeletal system, as well as to aspects of locomotion, to 
study dynamic contraction as it pertains to mechanical performance in mammals.  
 One of the most important aspects of muscle performance is power, which can be 
defined as the speed of muscle shortening against any given load (Josephson, 1993; 
Seow, 2013). In order to reach peak muscle power, muscle fibers that can produce the 
most amount of force in the shortest period of time must be recruited. These muscle 
fibers are aptly named fast-twitch fibers (type 2), and these become increasingly activated 
during more powerful and forceful muscle contractions. Unlike other muscle fiber types 
these fibers have the ability to potentiate, a mechanism suggested to assist fast twitch 
muscle fibers in achieving high forces very rapidly (Gittings et al., 2014). Potentiation 
may occur anytime these fibers are activated; a process that enhances mechanical power 
and thus improves performance. The following review will detail the major intracellular 
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mechanisms of muscle contractile functioning, with specific detail to the mechanisms of 
potentiation and how it can affect the attainment of peak power in mammalian skeletal 
muscle.  
1.2 Excitation-Contraction Coupling 
The molecular process by which vertebrate skeletal muscle converts chemical 
energy into mechanical force, work, and power is known as excitation-contraction 
coupling (Vandenboom, 2004), and is the basis for mammalian locomotion. Skeletal 
muscle contraction is induced by changes in resting membrane potential as a result of 
innervation from the central nervous system in the form of an action potential (AP) 
released down the spinal cord where it synapses directly/indirectly with a motor neuron. 
The motor neuron then transmits the AP down the length of its axon where it converges 
with the target muscle cell at the neuromuscular junction (Huxley, 1974). Release of 
acetylcholine (ACh) into the synaptic cleft results in the opening of ligand-gated sodium 
release channels on the motor end plate. A wave of Na+ depolarizes the sarcolemma and 
ensures further AP propagation down into the t-tubules of the cell (Huxley & Taylor, 
1958; Westerblad et al., 2010). The t-tubule network is continuous throughout the length 
of the cell with regular intervals extending inward for vast and hastily transmission of the 
chemo-electrical signal (Schneider & Chandler, 1973). During depolarization of the t-
tubules, both a voltage-sensing dihydropyridine receptor (DHPR) and its linked SR 
bound Ca2+ release Ryanodine (RyR1) receptor becomes activated (Allen, Lamb, & 
Westerblad, 2008; Chin, 2005; Dulhunty, 2006). The mechanism of connection between 
the two proteins is still unclear, albeit a conformational coupling process seems to be the 
likely cause (Beam & Bannister, 2010; Rebbeck, Karunasekara, Board, Beard, Casarotto, 
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& Dulhunty, 2014). Consequently, the SR releases an efflux of Ca2+ into the myoplasm 
(Allen et al., 2008). Released Ca2+ will bind to troponin C (TnC) on the actin filament 
allowing for weak binding of myosin heads to actin (Mckillop & Geeves, 1993; 
Vandenboom, 2004). Force is then generated through the hydrolysis of ATP within the 
myosin head, which acts as a molecular motor, and the subsequent movement of myosin 
against the actin filament powers contraction. When the activating stimulus is removed 
the decay of force is regulated by re-sequestration of Ca2+ into the SR by the Ca2+ ATPase 
pumps, leading to unbound myosin heads and muscle relaxation (Allen et al., 2008; 
Lamb, 2000).  
 
Figure 1. (MacIntosh, B. R., Holash, R. J., & Renaud, J. M. 2012) Excitation–contraction 
coupling and ATP usage in a skeletal muscle cell.   
increased rate of engagement, not a decrease in the rate of
dissociation of cross-bridges (Sweeney and Stull, 1990).
Levine and colleagues have shown that RLC phosphorylation is
associated with a change in the way in which the myosin heads are
ordered along the thick filament backbone (Levine et al., 1996). In
the unphosphorylated state, the myosin heads are packed tightly
along the thick filament. However, phosphorylation of the RLC
results in disorder of the myosin heads. This disorder was
interpreted as an increased mobility, such that the myosin head
can swing away from the thick filament, bringing the myosin head
into close proximity to actin and, hence, increasing the probability
of its interaction with actin.
So, the regulation of [Ca2+]i during contraction and
phosphorylation of myosin light chain can have significant
impact on ATP usage. Although RLC phosphorylation is
typically associated with potentiation, this phosphorylation
persists when fatigue begins (MacIntosh et al., 1993). The
same Ca2+–calmodulin complex that activates MLCK also
inhibits Ca2+ release (Boschek et al., 2007; Xiong et al., 2006).
The muscle is capable of decreasing the release of Ca2+, while
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1.3 Contractile Apparatus Microanatomy 
The sarcomere is known as the functional unit of the muscle cell. Within each 
sarcomere lies two distinct series of filaments, actin and myosin, that interact to produce 
force (Rayment et al., 1993a). It was originally hypothesized in 1954 that myosin and 
actin slid past each other forming a connection that generated force and muscle 
shortening (Huxley & Hanson, 1954; Huxley & Neidegerke, 1954). These research 
findings became the basis of the underlying mechanism of the sliding filament theory 
known today as crossbridge cycling (Craig & Woodhead, 2006). With regards to the 
potentiation of muscle force (see section 1.5), knowing the biochemical makeup of 
myosin will further the understanding of its role during potentiation and therefore is 
discussed below.  
1.3.1 Myosin Structure 
The skeletal isoform of myosin, the myosin 2, is part of the superfamily of myosin 
motor proteins (Vandenboom, 2004). Skeletal myosin dimers are long protein chains that 
consist of two identical motor proteins (Kendrel & Mooseker, 2005). Each dimer is 
composed of two individual myosin molecules with winding tails, which projects from 
the larger thick filament base. The other end of the tail splits to form separate necks, each 
consisting of two light chain proteins, and two heads (Uyeda, Abramson, & Spudich, 
1996). The tail of one myosin molecule runs anti-parallel to its adjacent neighboring 
myosin in a helical coiled-coil structure, thus forming the dimer. The distal portion of the 
tail is known as the C-terminus or light meromyosin region and provides self-association 
with the thick-filament backbone. The proximal portion of the tail segment known as the 
S2 subunit, acts as a flexible and mobile rod (Craig & Woodhead, 2006). It is the S2 
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portion of the tail that connects to the N-terminus globular head (motor domain) and is 
partly responsible for contractile and motility functions. As stated above, the neck of the 
molecule - at the base of the head - contains two light chains: the regulatory light chain 
(RLC), and the essential light chain (ELC); together they constitute the light-chain 
binding domain (LCD). 
Each myosin heavy chain carries a molecular mass of ~220kD with the addition 
of the two light chains (~17-23kD each) making the overall myosin 2 molecule roughly 
520kD (Rayment et al., 1993b; Schiaffino & Reggiani, 1994). Fastidious detail is called 
for when describing the myosin head region, as it is the key functioning segment of the 
myosin molecule. The head encompasses a nucleotide binding domain (25kD) used to 
store and release energy in the form of adenosine triphosphate (ATP). The hydrolysis of 
this high energy phosphate is used to drive contraction (Rayment et al., 1993b). The head 
of myosin also forms a cleft from a 50kD heavy chain segment, as well as a 20kD 
segment, that hold positive charges that bind to the negatively charged amino acids 
within the actin molecule, in preparation for crossbridge cycling. 
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Figure 2. (Rayment et al., 1993a) A coloured myosin S1 schematic. Red represents the 50-kD 
actin binding cleft, blue represents the 20-kD actin binding region, and green represents the 25-
kD nucleotide binding domain. The essential and regulatory light chains are shown in yellow and 
purple, respectively.  
1.4 Crossbridge Cycling 
 The transduction of chemical-to-mechanical energy is facilitated by the 
interaction of the myofilaments. The putative mechanism of contraction is the cycling 
crossbridges that utilizes the energy from ATP hydrolysis to create force via filament 
sliding.  
1.4.1 ATP Hydrolysis 
 The crossbridge cycle begins when Ca2+ binds to TnC on tropomyosin resulting in 
a change in position along actin. When tropomyosin (Tm) twists and ‘rolls’ off of its 
previous location on actin, it reveals a binding site where the head of myosin will dock to 
actin, pulling it towards the centre of the sarcomere (Gordon, Regnier, & Homsher, 
2001). The acto-myosin complex is stabilized by docking of the S1 of myosin to actin, 
removing the steric-hindrance and forcing Tm away form the active site. This occurs 
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following the hydrolysis of ATP, and the resultant ADP and inorganic phosphate (Pi) 
become transiently captured within the nucleotide pocket (Gordon, Homsher, & Regnier, 
2000). The release of free energy during this time is also harnessed by conformational 
changes within S1. The relay helix, for example, responds to changes in the lower 50kDa 
domain by creating a kink that rotates the converter region 60° (reverse stroke) into the 
pre-power stroke position, in preparation for force production (Rayment, Smith & Yount, 
1996; Schiaffino & Reggiani, 2011).  
1.4.2  Actin Binding and Product Release 
The 50kDa domain of myosin strongly binds to actin by fully closing the actin 
binding cleft. This causes the converter domain to rotate again, releasing the kink made 
during the pre-power stroke, straightening the neck, and releasing Pi from the nucleotide-
binding pocket. Release of Pi initiates the power stroke by relaying the information 
through the converter domain to the lever arm of the S1; this amplifies small changes at 
the active site into large changes within the neck region needed to transport actin 4-10nm 
closer to the sarcomere centre (Geeves & Holmes, 1999; Gordon et al., 2001; Uyeda et 
al., 1996). The release of Pi provides the final chemical to mechanical link that results in 
force production. 
 Several loops and switches within the myosin head are also highly important 
during actin binding and Pi release. For example, loop 2 may contribute to the 
stereospecific binding to actin and trigger Pi release. Furthermore, Sweeney and 
Houdusse (2010) offer that Pi release may be central to the role of switch one. After 
myosin-actin binding, movement of switch one provides a ‘back door’ escape for Pi, 
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which is then pinched off and removed without movement of the neck region or alteration 
of ADP release (Sweeney & Houdusse, 2010).   
1.4.3 ADP Release 
Force generation can occur irrespective of ADP release from myosin; however, 
continuous crossbridge cycling is dependent upon full release of ADP from the 
nucleotide pocket. As shown in figure 3, once Pi is released from myosin and the power 
stroke has occurred, ADP is left clinging within the nucleotide pocket. Upon release of 
ADP, the crossbridge enters the nucleotide-free rigor conformation. Under these 
conditions myosin is weakly bound to actin, very briefly, and shortly after, ATP will then 
rebind to the myosin head (post-rigor) causing rapid dissociation from actin due to a loss 
in affinity (Rayment et al., 1993a). The post rigor state is also short-lived and precedes 
the hydrolysis of ATP to ADP+Pi where the myosin heads re-cock and prepares for future 
binding to actin (see Figure 3).  
Interestingly, the release of ADP is believed to be strain dependent and therefore 
is affected by contraction parameters. For example, it is postulated that when muscles are 
stimulated to contract against a heavy load ADP is held within the pocket for a longer 
duration than at low loads, and under this heavy strain a further rotation of the converter 
domain is needed to release ADP. As a result of the prolonged ADP bound state, an 
increase in force occurs without further ATP utilization (Nyitrai & Geeves, 2004).  
Consequently, when the muscle produces high forces, speed becomes sacrificed; in 
contrast, as absolute force drops, velocity of muscle shortening rises (Sweeney & 
Houdusse, 2010). This phenomenon is in part related to the Fenn effect, which describes 
how muscle shortening is more metabolically costly than isometric contractions (Geeves 
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and Holmes, 1999; Sweeney and Houdusse, 2010). If speed or movement - in the form of 
shortening - is the end goal of contraction, ADP will be released faster than at high forces 
(isometric) and will therefore increase liberated energy (Gordon et al., 2001; Sweeney & 
Houdusse, 2010). In fast twitch skeletal fibers myosin is able to maximize shortening 
velocity and power production by rapid detachment of ADP from myosin and myosin 
dissociation from actin. This is followed by rapid ATP binding to myosin and the 
crossbridge cycle can continue as myosin docks to actin farther up the filament. 
Figure 3. Llinas, Pylypenko, Isabet, Mukherjea, Sweeney, & Houdusse (2009). Crossbridge cycle 
of skeletal muscle contraction showing the hydrolysis of ATP. The inner schematic represents 
transitional states of actomyosin complex proposed by Lymn and Taylor (1971).  
1.5 Potentiation 
 Muscle activation can lead to two very different states/changes in performance: 
fatigue, the decrease of expected force or work, or potentiation, the enhancement of 
expected force or work (Abbate et al., 2001; Grange et al., 1995; Westerblad et al., 1991). 
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Although opposing, fatigue and potentiation may also coexist and mask the presence of 
the other during prolonged or high frequency activation (Krarup, 1981; Rassier & 
MacIntosh, 2000).  Potentiation can be defined as the transient increase in muscle force 
observed after contractile activity (Brown & Loeb, 1999; Close & Hoh, 1968; 
Vandenboom, Gittings, Smith, Grange, & Stull, 2013). As a fundamental property of fast 
twitch skeletal muscle fibers, potentiation enhances muscle performance under a variety 
of conditions. 
1.5.1  Background 
 The mechanism for twitch force potentiation has been studied for over 100 years 
(Lee, 1907) and is known to be an intrinsic muscle phenomenon (Botelho & Cander, 
1953; Ramsey & Street, 1941; Standaert, 1964). Potentiation was first believed to be the 
result of accumulated chemical mediators in the muscle (Guttman et al., 1937). Work by 
Brown and von Euler (1938), Rosenblueth and Morison, (1937) and Zingoni (1954), 
implicated sources such as sodium, potassium, and acetylcholine as the causes for the 
heightened contractile response after repeated stimulation. More recent work, however, 
suggests that phosphorylation of myosin and changes in Ca2+ homeostasis may be 
responsible (Gittings et al., 2011; Smith et al., 2013; Vandenboom et al., 2014). Both of 
these divergent mechanisms are suggested to occur in concert with one another in a 
stimulus frequency and duration dependent manner (Moore & Stull, 1984). In contrast, 
stimulation of slow-twitch muscle produces minimal potentiation or even depressed 
responses to stimulation (Moore & Stull, 1984). This fiber type dependence may resonate 
in differences in myofilament structure, interfilament spacing, or excitation-contraction 
coupling process (Stull et al., 2011; Vandenboom et al., 2013).  
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 The two most common forms of activity dependent potentiation are staircase and 
post-tetanic potentiation (PTP). Originally termed ‘treppe’, staircase potentiation is 
characterized as a progressive increase in twitch force during a prolonged period of low 
frequency stimulation (Moore & Stull, 1984), whereas post-tetanic potentiation (PTP) is 
an increase of twitch force after a brief period of high frequency stimulation (Close & 
Hoh, 1968). Not surprisingly, as the result of different stimulation paradigms, both 
exhibit a different time course of dissipation. For instance, upon cessation of the 
contractile stimulus, staircase potentiation displays a slow initial decrease in force 
followed by a more rapid drop thereafter (Krarup, 1981a). For PTP the twitch force 
following a tetanic conditioning stimulus is rapidly subdued followed by a slower 
dissipation over several minutes (Vandenboom et al., 2013).  
 Regardless of the form, it appears that potentiation selectively enhances muscle 
function. For example, there are potentiation dependent differences in contraction type 
(concentric>isometric>eccentric), length (shorter than Lo >longer than Lo), temperature 
(higher temperatures>lower temperatures), as well as sporadic differences between 
species (Abbate Sargeant, Verdijk, & De Haan, 2000; Caterini, Gittings, Huang, & 
Vandenboom, 2011; Gittings, Huang, & Vandenboom, 2012; Xeni et al., 2011). Post-
tetanic potentiation also exhibits a concentric speed dependence such that twitch force 
increases with faster sliding velocities (Caterini et al., 2011; Gittings et al., 2012; Xeni et 
al., 2011). Thus, a multitude of experimental conditions may alter potentiation and 
therefore care must be taken when attributing results to specific mechanisms (see 
Appendix B: Compilation of studies examining potentiation) 
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1.6 RLC Function 
 The light-chain binding domain is part of the S1 subunit of myosin and is 
dedicated to modulating contractile dynamics and providing mechanical stability. In 
addition to its structural role, post-translational modification of the RLC modulates 
myosin motor function, an effect that increases the calcium sensitivity of the thin filament 
during submaximal force generation (Persechini, Stull, & Cooke, 1985; Sweeney & 
Kushmerick, 1985; Sweeney & Stull, 1990).  
1.6.1  RLC Phosphorylation Pathway 
 Existence of a phosphorylatable site on the myosin regulatory light chain 
(Blumenthal & Stull, 1980; Perrie, Smillie, Perry, 1973; Stuart et al., 1998) provided a 
plausible intracellular mechanism for potentiation, and in particular, during PTP. 
Interestingly, the same Ca2+ signal that initiates contraction also employs a signaling 
cascade that phosphorylates the RLC (Klug, Botterman, & Stull, 1982; Zhi et al., 2005). 
As part of this cascade Ca2+ binds to calmodulin: a ubiquitous Ca2+ binding protein. 
Calmodulin contains four resident Ca2+ binding sites that when occupied enables it to 
bind to and form a holoenzyme with skeletal myosin light-chain kinase (skMLCK) 
(Blumenthal & Stull, 1980). Binding of calmodulin to skMLCK occurs almost 
simultaneous with contraction although activation of the catalytic process and RLC 
phosphorylation is slower (Stull, Kamm, & Vandenboom, 2011). After a series of 
conformational changes the calmodulin-skMLCK connection prompts the catalytic 
segment of skMLCK to displace from its regulatory sub-unit allowing the RLC N-
terminus to bind the catalytic segment. Upon RLC binding, the cleft within the catalytic 
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segment closes and the ATP within skMLCK transfers Pi to the RLC (see figure 4 for 
pathway).  
1.6.2    skMLCK Kinetics 
 Similar to the steric blocking mechanism displayed by the thin filament, skMLCK 
has an auto-inhibitory component existing between the large catalytic core and the 
calmodulin binding sequence (Padre & Stull, 2000a; Padre & Stull, 2000b). In essence, 
this component is an intrasteric regulator, which controls the activity of skMLCK by 
remaining inactive without calmodulin binding; yet allows ATP binding (Krueger, Padre, 
& Stull, 1995). Under steady state conditions (Ca2+ present) both the RLC and ATP are 
allowed as substrates of the calmodulin-skMLCK complex. 
 
 
 
 
 
 
Figure 4. (Kamm and stull, 2011) The molecular signaling cascade initiating phosphorylation of 
the myosin regulatory light chain. 
 The time between periods of activation and the frequency of stimulation (Hz), 
determines the percentage of skMLCK activated. This is due to the slow rate of 
calmodulin dissociation from skMLCK that in turn affects dissociation of Ca2+ from 
calmodulin (Ryder et al., 2007). The result is an increased fraction of phosphorylated 
myosin heads. In addition, the activity of the protein phosphatase (MLCP) that cleaves 
the phosphate from the RLC is much slower (~50 fold) than skMLCK-induced 
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phosphorylation (Manning & Stull, 1982; Moore & Stull, 1984). Therefore, during brief 
activation (<10secs), the MLCP activity is offset by skMLCK activity, an effect that may 
enhance contractile performance by increasing the fraction of cycling crossbridges in the 
force generating state (Stull et al., 2011). Stull et al. (2011) referred to the history 
dependent nature of phosphorylation as a biochemical memory that improves the future 
contractile response within fast twitch muscle fibers. After cessation of the stimulus and a 
period of relaxation, the unregulated MLCP activity (Morgan, Perry, & Ottaway, 1976) 
continues to slowly de-phosphorylate the RLC until it returns to resting levels. 
1.6.3  RLC Phosphorylation-Mediated Potentiation  
 As described by Stull and colleagues, RLC phosphorylation catalyzed by 
skMLCK, may be the principle mechanism of PTP. In support of this, stimulation 
induced increases in RLC phosphate content has been temporally correlated with 
increases in twitch force potentiation, (Abbate, Van Der Velden, Steinen, & De Haan, 
2001; Grange, Cory, Vandenboom, & Houston, 1995; Klug et al., 1982; Moore & Stull, 
1984; Xeni et al., 2011) in some cases, phosphorylation has increased ~5 fold from rest 
following a tetanic conditioning stimulus (Grange et al., 1995; 1998). However, the link 
between RLC phosphorylation and the precise modification of crossbridge dynamics is 
still unclear. For example, RLC phosphorylation has been suggested to increase the rate 
of cross-bridge attachment to actin (Sweeney & Stull, 1990); yet also may increase the 
force per cross-bridge (Childers & MacDonald, 2004). It has been thought that the latter 
change occurs by augmenting the power stroke portion of the crossbridge cycle (Davis et 
al., 2002; Sweeney et al., 1993), however, considering that tetanic force is unaltered when 
potentiated, this mechanism is unlikely. The first mechanism, however, which is based on 
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alterations to Fapp, is the most likely source of force enhancement. This model is based on 
work by Huxley (1957), who proposed that there are two states of crossbridge cycling 
represented by rate constants: F & G. Modified by Brenner (1988), Fapp represents the 
transition of crossbridges from a non-force generating to a force generating state. Gapp on 
the other hand, represents the reverse transition where crossbridges cycle from a force 
generating to a non-force generating state. Similar to Ca2+ binding on TnC, it is suggested 
that RLC phosphorylation enhances force production by increasing Fapp without affecting 
Gapp (Brenner, 1988; 1990; Sweeney & Stull, 1990) and will therefore increase the 
fraction of cycling crossbridges able to attain the force generating state (Metzger, 
Greaser, & Moss, 1989; Sweeney & Stull, 1990). In addition to this, research examining 
the flight pattern of drosophila melanogaster (fruit fly) found decreased flight fluency in 
mutated RLC’s incapable of phosphorylation. It was determined that the reduced number 
of attached crossbridges in mutated flies links to a reduction in Fapp and reflects the 
reduction in power output. As a result, sufficient power output for flight was lost without 
the ability to phosphorylate the RLC (Dickinson et al., 1997), indicating that this 
mechanism is required for normal/ optimal functioning in some species.  
 The increased rate of crossbridge attachment is also corroborated by structural 
studies on myosin thick filaments. These studies have shown that when the RLC is 
phosphorylated the myosin head moves away from the thick filament backbone and is 
displaced towards the thin filament (Alamo et al., 2008; Brito et al., 2011; Levine, 
Kensler, Yang, Stull, & Sweeney, 1996; Levine et al., 1998). Similarly, the orderly 
arrangement of myosin heads may be disrupted by phosphorylation by weakening the 
inter-molecular interactions between adjacent heads (Alamo et al., 2008). Furthermore, 
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work form Sweeney, Yang, Zhi, Stull, and Trybus (1994) suggested the addition of a 
phosphate moiety to the RLC may reverse the electrostatic interaction of the surrounding 
positively charged amino acids and another yet to be determined structure. Regardless of 
mechanism, the closer association of actin to myosin promotes crossbridge formation at a 
given submaximal level of [Ca2+]. 
1.7 Force-Frequency Relationship of Potentiation  
 The potentiation of force is directly influenced by stimulation frequency and 
duration. For example, although dependent on experimental conditions (e.g., temperature 
and species), potentiation of muscle force has been observed at all sub-tetanic 
frequencies; however, as stimulation frequency increases there is a simultaneous decrease 
in potentiation (Abbate et al., 2000; Brown & Loeb, 1998; Burke et al., 1976; Krarup, 
1981; Gittings et al., 2012; MacIntosh et al., 2008). Thus, while force production in both 
fast and slow fibres is proportional to stimulation frequency, the influence of RLC 
phosphorylation on force is inversely related to stimulation frequency. Furthermore, this 
signifies that the influence of potentiation diminishes as muscle force nears maximal, 
even for high levels of RLC phosphorylation. Similarly, during isotonic contractions 
when the muscle shortens, MacIntosh and Bryan (2002) detected a large increase in 
shortening amplitude and shortening velocity at the onset of contraction that faded 
towards the end of a 7s contraction. They attributed this to the muscle approaching near 
maximal shortening amplitude and shortening velocity for the given stimulation 
paradigm; yet during this time, RLC phosphorylation still increased in a linear manner. 
These findings support the role of RLC phosphorylation in increasing Fapp at submaximal 
but not maximal Ca2+ activation levels (Sweeney et al., 1993), and furthermore, is 
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consistent with studies showing that potentiation does not improve maximal shortening 
velocity (Butler et al., 1983; Gittings et al., 2011; Palmar & Moore, 1989). Indeed, during 
isovelocity shortening contractions of mouse EDL, potentiation seems to be inversely 
related to force (Gittings et al., 2014). This is consistent with increased potentiation for 
concentric than isometric contractions at a given frequency, as well as increased 
potentiation present as shortening velocity increases (Caterini et al., 2011; Gittings et al., 
2012; 2014; Xeni et al., 2011). Moreover, skinned fiber data showing that potentiation is 
inversely proportional to the strongly bound crossbridge population supports the idea that 
RLC phosphorylation mediated potentiation is force dependent (i.e., more force, less 
potentiation) for all contractions (Sweeney & Kushmerick, 1985; Sweeney & Stull, 
1990).  
1.8 Secondary Mechanism of Potentiation 
 Development of knockout mice devoid of the skMLCK enzyme (skMLCK-/-), 
which are unable to phosphorylate the RLC, has provided a negative control for 
comparison to WT mice. This genotype enables the relative contribution of RLC 
phosphorylation to potentiation to be separated from other potential mechanisms. For 
example, in 2005, Zhi et al. compared isometric twitch force potentiation in EDL of WT 
and skMLCK-/- mice. In all cases skMLCK-/- mice had severely attenuated PTP and a 
50% reduction in staircase responses when compared with WT, signifying that RLC 
phosphorylation is the largest, but not the only, component of isometric twitch force 
potentiation. Gittings et al., (2011) also found that potentiation of isometric twitch force 
caused by PTP was selectively inhibited by the ablation of the skMLCK gene in fatigued 
muscle.  
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 The residual staircase potentiation seen in skMLCK-/- mice implicates an alternate 
mechanism for potentiation (Zhi et al., 2005). To this end, a stimulation induced increase 
in myoplasmic [Ca2+] has been suggested. To study this effect, Smith et al. (2013) used 
the mouse lumbrical, a unique WT muscle that displays isometric twitch force 
potentiation in the absence of RLC phosphorylation. This model is therefore able to 
isolate the contribution of altered [Ca2+] to potentiation. Increases in resting myoplasmic 
[Ca2+] were correlated with PTP in the absence of RLC phosphorylation although the 
exact mechanism still remains unknown. It has been hypothesized that an increased 
resting myoplasmic [Ca2+] that reduces the buffering capacity of parvalbumin enables a 
larger quantity of free Ca2+ released from the sarcoplasmic reticulum to bind TnC 
(MacIntosh, Taub, Dormer, & Tomaras, 2008; Smith et al., 2013). Future research should 
seek to quantify the calcium potentiated force potentiation during dynamic contractions to 
further improve understanding of potentiation during locomotion and possibly the role in 
vivo.   
1.9 Muscle Power Output & Locomotion 
 Power, as it relates to muscle, is the product of speed of shortening and the force 
produced during shortening. It is essential for locomotion and has varying demands as the 
mode of locomotion changes. For example, as movement speed increases in rodents from 
a walk to a trot and again to a gallop, the type of muscle fibers required for movement 
changes from slow to fast twitch fibers (Armstrong et al., 1997). This occurs because fast 
twitch fibers are able to shorten against loads at faster speeds of shortening than slow 
twitch fibers. During fast cyclical movements muscles must stretch and shorten very 
rapidly while maintaining power output. In order to move faster, frequency of stimulation 
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must increase to provide more force; alternatively, fast twitch fibers can also potentiate, 
which may effectively reduce power loss during the shortening portion of locomotion. 
 Locomotion shares many traits among different species; some of which are not 
mammals. For example, comparisons can be drawn between the gait patterns of lizards, 
crabs, dogs, and humans alike. During a running gait pattern each of these species uses 
stored elastic energy created from kinetic and gravitational potential energy to propel 
them forward into flight. Unfortunately, most circumstances requiring locomotion are not 
as simple as exchanging stored potential energy into movement. For most species the 
environment is dynamic and constant bombardment with external perturbations is the 
norm. As such, the motor system must modulate muscle output relentlessly to achieve 
smooth locomotion. Importantly, understanding the role of a particular muscle, including 
the stimulation frequency and the timing of activation, will allow for better study and 
understanding of the in vivo functioning. For example, some muscles act as motors while 
others work as brakes to provide a well-rounded system for locomotion (Azizi, 2014).  
1.9.1    Potentiation and Crossbridge Kinetics 
 Results from skinned fibers demonstrate that RLC phosphorylation enhances 
submaximal forces by altering crossbridge kinetics during isometric contractions. This 
manifests as an increase in the rate of force development (+dF/dtmax) during potentiated 
isometric twitches and tetanic contractions (Vandenboom, Grange, & Houston, 1995; 
Vandenboom, Xeni, Bestic, & Houston, 1997). The increase in +dF/dtmax is greater at 
shorter lengths, while the rate of relaxation is independent of length (Brown and Loeb, 
1999). Together, these kinetic changes augment peak twitch force and prolong the state of 
tetanic force generation. The enhancement of peak force may extend to brief tetanic 
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stimulation also (MacIntosh & Willis, 2000). Similarly, during potentiated concentric 
contractions the +dF/dtmax may increase independent of stimulation frequency and 
shortening velocity (Gittings et al., 2012). This allows for greater sub-tetanic forces 
during fast shortening velocities elicited by high frequency pulses (Abbate et al., 2000). 
In doing so, the total work and power done by the muscle over the period of a contraction 
also increases. In contrast, skMLCK-/- mice display no increase in +dF/dtmax during 
concentric contractions (Gittings et al., 2014) and during isometric tetani, and 
furthermore, tetanic -dF/dtmax is quickened rather than slowed (Gittings et al., 2011). 
Thus, a reduction in power output may be seen in these mice compared with WT, 
implicating a positive role for RLC phosphorylation.  
1.9.2  Potentiation of Power Output 
 It has been proposed that the potentiated state may actually be the normal working 
state of fast-twitch muscle fibers (Brown & Loeb, 1998). Under this assumption, a 
physiological role for RLC phosphorylation must include dynamic contractions. 
Interestingly, PTP has a greater effect during concentric contractions compared to that of 
isometric contractions (Caterini et al., 2011; Grange et al., 1995; 1998; Xeni et al., 2011). 
Contrary to this, the effects of PTP during eccentric contractions are severely attenuated 
in both skinned fibers and isolated skeletal muscle preparations (Caterini et al., 2011; 
Childers & McDonald, 2004). Therefore, the potentiation of power output during 
dynamic functioning is selective to concentric contractions. This is most likely the result 
of the inverse relationship between magnitude of potentiation and thin filament activation 
(Davis & Sartorius, 2002; Gittings et al., 2014; Metzger et al., 1989; Patel et al., 1996; 
Sweeney & Kushmerick, 1985; Sweeney & Stull, 1990), an effect that may be enhanced 
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during shortening by sensitizing the contractile apparatus to RLC phosphorylation via 
thin filament deactivation or increases in Gapp (Gittings et al., 2012; Stull et al., 2011). 
 The relative force attained for a given frequency of stimulation is lower when 
shortening than isometric. Considering that potentiation is inversely related to force 
(Gittings et al., 2014) this suggests that higher stimulation frequencies will potentiate 
shortening compared to isometric contractions. This is corroborated by data from intact 
rat gastrocnemius muscle displaying larger increases in force potentiation from brief high 
frequency pulses (200-400Hz) during isotonic shortening compared with isometric 
contractions (MacIntosh, Taub, Dormer, & Tomaras, 2008). These results are in 
agreeance with the rightward shift in the force-frequency curve during shortening 
compared to isometric contractions, implying that higher stimulation frequencies are 
needed to fully activate muscle while shortening (Abbate et al., 2000). Furthermore, 
potentiation also shifts the force-velocity relationship such that force is increased at 
almost every shortening velocity and vice versa (Gittings et al., 2012; Grange et al., 1995; 
1998). Therefore, it is plausible that power output may be positively influenced over the 
range of physiological shortening speeds and high frequency activation patterns such as 
that observed by Abbate et al. (2000).  
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Figure 5. Schematic representing the hypothetical shift in power output between different states 
of muscle activation i.e., unpotentiated and potentiated. Shaded area (grey-fill) denotes the 
potential range that optimal velocity may occur at, depending on level of potentiation. Figure is 
based on ‘in vitro’ mouse EDL muscle stimulated at 100Hz. 
  
 Interestingly, the shift in the force-velocity relationship also occurs, albeit, to a 
lesser extent, in skMLCK-/- mice (Gittings, Bunda, & Vandenboom, unpublished); this 
indicates that changes in resting myoplasmic [Ca2+] may also potentiate force, work, and 
power. Nonetheless, given that RLC phosphorylation may enhance tetanic +dF/dtmax and 
decrease -dF/dtmax, prolonging force production at contraction end, this mechanism may 
play an important role in modulating muscle performance in vivo (Grange et al., 1995). 
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STATEMENT OF PROBLEM 
 
 Historically, PTP has been mostly studied using isometric contractions at low 
frequencies of stimulation (Krarup, 1981; Klug et al., 1982; Manning & Stull; Moore et 
al., 1990; Vandenboom et al., 1993; 1995). Interestingly, when studied using dynamic 
contractions these have been shown to potentiate to a greater extent than isometric in both 
rat and mouse muscle (Abbate et al., 2000; Caterini et al., 2011; Childers & McDonald, 
2004; Grange et al., 1995; 1998; Xeni et al., 2011). In addition to this, many of these 
studies noted a pronounced augmentation of power when muscles were in the potentiated 
state (Abbate et al., 2000; Caterini et al., 2011; Grange et al., 1995; 1998), however, these 
studies have not been able to directly examine the contribution of RLC phosphorylation 
to power during shortening contractions. Therefore, a main impetus of this study is to 
separate the impact of RLC phosphorylation from other possible mechanisms of 
potentiation through use of skMLCK-/- mice. Lastly, deciphering which mechanisms 
contribute to the rightward shift observed in the power-velocity curve to higher 
shortening velocities (i.e., Abbate et al., 2000) still remains unknown. Therefore, these 
factors need to be examined further before we can fully understand the physiological 
utility of the RLC phosphorylation mechanism in enhancing mechanical function in 
vertebrate striated muscle. 
2.1 Purpose  
 1. The main purpose of this study was to determine the impact of RLC 
phosphorylation mediated force potentiation on mechanical power of mouse EDL muscle 
(in vitro, 25° C).  To this end we compared both the mean and peak resting and 
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stimulated power outputs of WT and skMLCK-/- muscles (with and without RLC 
phosphorylation, respectively) under experimental conditions designed to mimic 
physiologically relevant contractions.  
 2. A secondary purpose of these experiments was to determine whether the 
absence of RLC phosphorylation negated the shift in the power-velocity curve to higher 
shortening velocities expected to occur in potentiated WT muscles.  
 
Note: Mean power is a measure used to describe an entire contraction. As an added 
measure to delineate genotypic differences in mean power we analyzed the contractile 
kinetics of each muscle: maximum rate of force development (+dF/dt), maximum rate of 
force relaxation (-dF/dt), time to peak tension (TPT), and half relaxation time (½RT), 
were used to assess these differences. Furthermore, as a confirmatory measure, RLC 
phosphorylation content was analyzed for differences between genotypes pre and post-
CS. 
2.2 Hypotheses  
 1.   Concentric power output of potentiated EDL muscles will increase to a 
greater extent in WT than skMLCK-/- muscles at all speeds of shortening. 
 2.  Peak concentric power output of potentiated EDL muscles will increase to 
a greater extent in WT than skMLCK-/- muscles. 
 3.  The shift in the power-velocity relationship to higher speeds of shortening 
will be observed in WT but not in skMLCK-/- EDL muscles. 
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2.3 Assumptions 
There are no phenotypic differences other than the skMLCK gene knockout and the 
coat colour (black and agouti) i.e., body weight and composition.  
There are no cellular adaptations in skMLCK-/- that result in RLC phosphorylation. 
Length changes will not induce large variations in passive tension since the elastic 
components will not be stretched and the contractions will be shortening from slightly 
over optimal length (1.05-0.90Lo).  
 Any potentiation in skMLCK-/- mice will be due to altered (Ca2+resting) 
homeostasis. 
2.4 Limitations 
The use of only one stimulation frequency during the experimental protocol 
minimizes extrapolation of findings to a narrower range than if a range of frequencies 
were used.   
Not all contractions will produce force over the entire shortening cycle. As a 
consequence of constant pulse number, only the contractions that use the fastest 
percentage of maximum shortening velocity will create force over the majority of the 
shortening ramp.  
METHODS 
3.1 Mice  
Adult male wildtype and skMLCK-/- mice were used in these studies. All mice were 
selected at a minimum age that accorded with sexual maturation, as previously described 
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(Fox, 2006).  Wildtype C57BL/6 mice (male, age 3-6 months, 27.6 ± 2.0 g) were ordered 
from Charles River- Drummondville, QC, Canada, and were housed at Brock for ~1-2 
week before experiments began. The skMLCK-/- mice (C57BL/6 background) were 
obtained from our own breeding colony at Brock University (male, age 2-5 months, 23.2 
± 1.2 g) and were housed in the Comparative Biology Facility. Coat colour in the 
skMLCK-/- mice were backcrossed to the C57BL/6 genotype for nine generations to 
ensure subsequent generations were homozygous dominant for the agouti coat colour. 
This enables a clear visual distinction between the two genotypes. More details regarding 
the generation and characterization of the skMLCK-/- mice have been presented 
previously (Zhi et al. 2005; Gittings et al. 2011). All mice were fed standard chow and 
water ad libitum and were maintained on a 12h/12h night/day cycle. All procedures 
utilized during the experimental protocol received full ethical approval from the Brock 
University Animal Care and Use Committee (Protocol # 13-03-02).   
3.2 Surgical Intervention and Cardiac Injection 
 On the day of an experiment adult mice were transported from caging in the 
Comparative Biology Facility to the experimental area in our laboratory. Following this, 
the mice were anaesthetized with a peritoneal injection of sodium pentobarbital (0.025 
ml/g body weight), diluted with 0.9 % saline in a 1 ml syringe. The extensor digitorum 
longus (EDL) muscle was then surgically removed with both proximal and distal tendons 
tied off by non-absorbable braided silk suture (4-0) and then the muscle was suspended in 
a jacketed vertical organ bath (Radnoti Glass Technology, Inc.). The bath contained 
Tyrode’s solution (in mM): 121 NaCl, 5 KCl, 24 NaHCO3, 0.4 NaH2PO4, 0.5 MgCl2, 
1.8CaCl2, 5.5 D-Glucose, and 0.1 EDTA, that was continuously gassed (95% O2, 5% 
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CO2), maintaining a stable pH (7.4) and maintaining the muscle preparation at 25o C, 
using an Isotemp 3013S circulator. After suspension, the second EDL muscle was 
extracted and placed in a separate oxygenated bath (95% O2, 5% CO2) containing 
Tyrode’s solution, surrounded by ice. After the muscle had been carefully excised from 
the hind limb, the mouse was euthanized with a lethal intracardiac injection of sodium 
pentobarbital (0.025 ml/g body weight), diluted with 0.9 % saline in a 1 ml syringe, and 
was properly disposed of according to the Brock University animal care facility 
procedures. After collection of contractile data for the first EDL muscle and before 
mounting of the second EDL muscle, a fresh aliquot of Tyrode’s solution was added to 
the vertical bath. 
3.3 Experimental Apparatus 
All experiments utilized a customized in vitro muscle testing system (Aurora Scientific 
Incorporated) capable of adjusting muscle length and controlling a variety of 
environmental factors. After surgery was performed within each experiment, muscle 
stimulation of the EDL was applied using flanking platinum electrodes, provided by a 
Model 701B biphasic stimulator (ASI) with voltage set to 1.25 times the threshold 
required to elicit maximal twitch force (refer to equilibration protocol for determination 
of threshold, section 3.4). Following muscle suspension, the isometric resting muscle 
length was determined, within 0.01 mm, using a horizontal stereo zoom microscope 
(Bausch and Lomb) and a sliding micrometer (Velmex, Inc.). A 20-30 minute 
equilibration period then took place followed by measurement of the muscle’s optimal 
length (Lo), deemed to be the length associated with maximal isometric twitch force. 
During experiments, muscle length and force data was monitored via LINUX software 
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and controlled by a dual mode servomotor (Model 305B, Aurora Scientific Inc., Aurora 
ON). All experiments were collected at 2000 Hz and saved to computer for further 
analysis (ASI 600a software).  
3.4 Equilibration & Finding Optimal Length 
Each experiment began with a preliminary set of protocols devised to reduce 
unsystematic error by monitoring muscle viability and by ensuring proper experimental 
set up i.e., muscle placement and suture tying. Initially, optimal length (Lo) for maximal 
isometric twitch force production was roughly estimated by measurement through the 
stereo zoom microscope (tendon to tendon) and set as ‘reference length’ in the computer. 
The EDL was then stimulated with a 400 ms (150 Hz) tetanus, to remove any slack or 
compliance within the muscle and to test for possible slipping of the suture on the tendon. 
Muscles were then equilibrated for 30 minutes during which a 1 Hz, 100 ms twitch was 
elicited every 3 minutes, whereby intensity of stimulation (current) was gradually 
increased until a maximal twitch force was observed. The stimulus intensity was then 
increased 25% to confirm activation of all muscle fibers. Following the 30 minute 
equilibration period, optimal length for isometric twitch force (Lo) was determined by 
administering twitches to the muscle at varying lengths between 1.1-0.90 Lo via written 
‘optimal length’ protocol. The resting tension that corresponded with the highest peak 
was used to set the muscle for a secondary observation of length under the stereo zoom 
lens. The new ‘adjusted’ length was set as Lo and used as reference for the remainder of 
the experimental protocol in order to normalize force values between experiments. 
  29 
3.5 Extensor Digitorum Longus 
The Extensor Digitorum Longus (EDL) is a highly studied muscle model for 
investigating rodent muscle biophysics (Wilson & James, 2004). Traditionally the EDL 
was examined for assessing locomotion, work and power output of hindlimb muscles; 
more recently it has been used to investigate mammalian skeletal muscle potentiation, as 
a result of the high quantity of fast glycolytic fibres existing within the muscle. In order 
to properly understand the use of the EDL within the existing scientific literature, a brief 
synopsis of the underlying physiological properties, as well as the more visible 
mechanical properties of the muscle, must be illustrated. 
 The mouse EDL muscle is located in the hindlimb and acts to extend the toe and 
raise the foot into dorsi flexion. In the instance of locomotion the EDL provides a spring 
like motion to the foot at the beginning of the swing phase, slightly after the foot has 
propelled itself from contact with the ground. Neural activation begins during flight and 
ends shortly after landing (James, 1995). From this standpoint, the muscle’s main action 
during movement is to play a synergistic role in maintaining steady limb movement. 
Structurally, all of the dorsi-flexors of the hindlimb have longer fiber lengths with small 
cross-sectional areas that provide high velocities of shortening, and thus, movement 
during the swing phase becomes easily modulated based on locomotor needs (Lieber, 
1997).  
 By implanting electrodes in freely moving rats, Hennig and Lomo (1985) 
determined that EDL motor units are active for approximately 5-22% of a 24hour period 
(Hennig and Lomo, 1985). This is indicative of the high quantity of fast-twitch fibers 
within the muscle: 5.3% (2a), 3.3% (2a/x), 24.5% (2x), 6.8% (2x/b), 59.7% (2b), 
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(Gittings et al., 2011). Combined with work from other hindlimb muscles, this model will 
further our understanding of the dynamics of movement.  
 Lastly, this muscle model was chosen because it is small enough to maintain 
viability over a long period of time through diffusion of sufficient oxygen and substrates 
into the cell (Barclay, 2005). Moreover, it has previously been demonstrated that rodent 
intact muscle preparations (EDL) remain stable for > 1 hour when maintained at 25oC 
(Segal & Faulkner, 1985).  
3.6 Experimental Design 
The mouse EDL was used to investigate the effects of RLC phosphorylation 
mediated potentiation on peak power output of mouse skeletal muscle. The choice of 
EDL muscle used for collection of contractile data first i.e., left vs. right leg, was 
alternated between mice to minimize confounding variables.  
Two identical sets of experiments were performed: one with the use of C57bl/6 
wildtype mice, the other using C57bl/6 skMLCK-/- mice. As previously stated, skMLCK-
/- mice provide a unique negative control since the gene coding for skeletal myosin light 
chain kinase has been removed, and therefore they display no stimulation induced RLC 
phosphorylation.  
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Figure 6. An overview of the sample size used for each experiment and the assignment of groups 
based on genotype. Each ‘subject, (n)’ represents a single EDL muscle; in some cases only one 
muscle was taken from the mouse dependent on proficiency of surgical removal.   
3.6.1  Experimental Design and Protocol 
Experiments investigated the effects of PTP on concentric power output at a range 
of shortening velocities (0.05-0.65 Vmax) in both wildtype (WT) and skMLCK-/- mice. 
The protocol had identical sets of shortening-ramps before and after the CS to illustrate 
the effects of PTP on power. Shortening-ramp amplitude was controlled by a dual-mode 
servomotor that shortened muscle length to simulate a concentric contraction in vivo. All 
muscles (n = 10) were stimulated at the same frequency (100 Hz), representing a value 
that was considered to be physiological (Abbate et al., 2000; Henig & Lomo, 1985) and 
has previously been shown to cause variations in power output after a tetanic 
conditioning stimulus (Gittings, 2012).  
The conditioning stimulus consisted of four independent brief high frequency 
bursts (100Hz) lasting 400ms each, within a total duration of 10 seconds. This type of 
stimulus paradigm has been previously shown to induce reproducible near maximal 
potentiation in mouse EDL muscles at 25o C, with minimal fatigue: denoted by a decrease 
in expected force, work, or power (Caterini et al., 2011; Gittings et al., 2012; 
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Vandenboom et al. 1997; Xeni et al., 2011). Each set of experimental conditions i.e., CS 
bracketed by shortening ramps, was separated by 15 minute rest periods to prevent 
fatigue and allow RLC phosphorylation to dissipate (Abbate et al., 2000).  
The protocol consisted of closely spaced concentric shortening ramps: the first 
ramp proceeding without stimulation, the second while being stimulated. The passive 
tension from the first ramp was subtracted from the total tension of the second ramp, thus 
giving active tension of the muscle during contraction. Active force was then used to 
calculate all contractile measures. Furthermore, every stimulated shortening ramp was 
activated by an equal number of pulses (3) in order to accurately compare work and 
power accomplished across the entire contraction. After the first set of ramps had 
finished, the muscle was subjected to a second set of ramps shortening at a different 
velocity. Each set of ramps was then tested after a potentiating stimulus (CS), making up 
a ‘single protocol’, for each WT and KO muscle, as shown in Figure 6. The order in 
which shortening ramps were administered over the course of an experiment i.e., 0.05-
0.65 Vmax was chosen at random and was strategically altered between muscles to control 
for the possibility of order effects.     
Each ramp shortened for a different period of time, corresponding to the time it 
took the muscle to shorten from 1.05 to 0.90 Lo at the desired shortening velocity. Within 
each stimulated ramp (active), stimulation began after shortening had begun (~1.045 Lo). 
Furthermore, this stimulation paradigm allowed for complete relaxation from concentric 
force by the end of each shortening ramp. The average/ peak force developed over the 
course of each contraction was then used in conjunction with velocity of shortening to 
find the PO of each muscle contraction. The starting length for shortening ramps (1.05 
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Lo) was chosen to prevent large variations in passive tension. As suggested by James 
(1995), starting lengths above 20% of Lo will create large-scale changes in viscoelastic 
tension within muscle. Furthermore, Longer muscle lengths also increase the calcium 
sensitivity of the myofilaments and will have force-modulating consequences that may 
confound the results of the shortening ramps used (Josephson, 1999).  
Figure 7. The experimental timeline for collection of contractile data (n = 10). Upper line 
represents force traces of shortening ramps (in blue) at rest and post CS. Each was paired (rest & 
stimulated) in order to acquire the active force produced by the contractile unit. Two different 
speeds were assessed during each protocol to reduce the length of the entire experimental 
procedure and prevent muscle damage/fatigue. The order of shortening ramp speed e.g. 0.10 & 
0.35 Vmax, 0.65 & 0.20 Vmax etc., was manipulated between protocols to prevent order effects. 
Lower line represents the change in muscle length for each shortening ramp, which was set at a 
constant 15% Lo (1.05-.90 Lo). 
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3.7 Determining Muscle Shortening & Ramp Velocity 
 The maximum velocity of shortening for intact whole muscle preparations are 
quantified in two ways: 1) The slack test, pioneered by Edman (1979) as a measure of the 
unloaded shortening velocity (Vo) of the fastest fibers within a muscle. 2) Maximum 
shortening velocity (Vmax) extrapolated from force-velocity properties of skeletal muscles 
fit to a curve using the Hill equation, (1937). Considering mouse EDL is a heterogeneous 
muscle, Vmax is therefore a better representation of the whole muscle’s maximum velocity 
of shortening. The current study used a Vmax value of 9.8 fiber lengths per second (fl/s) 
(Gittings et al., 2012) that is consistent with other studies for mouse EDL (Brooks & 
Faulkner, 1988, 1991). This value was then converted to muscle lengths per second (ml/s) 
using a ratio (0.44-0.45:1) proposed by previous studies (Brooks & Faulkner, 1988; 91; 
Grange et al., 1995; McCully & Faulkner, 1985), (see below for equation). This value 
was then converted to maximal percentage of optimal lengths per second (ex. 444% Lo/s), 
another unit equating to Vmax. Converting to this unit is instrumental in determining the 
time it will take each ramp to shorten from 1.05 Lo to 0.90 Lo. Every shortening speed 
was then calculated as a percentage of the maximum Lo/s at which the muscle could 
shorten. Dividing the percentage of Lo/s by the distance of length change i.e., 1.05 Lo - 
0.90 Lo, calculates the duration of the length ramp. Example using 0.20 Vmax shortening 
ramp:  
 𝑓𝑙/𝑠 · 0.44   = 𝑉𝑚𝑎𝑥   𝑚𝑙/𝑠 = 4.31     4.31𝑀𝑙/𝑠   ×    100%  𝐿!/𝑠 = 431 
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0.20  𝑉𝑚𝑎𝑥 = 431𝐿!𝑠 ∙ 0.20  % = 86.2  %𝐿!/𝑠      15  %𝐿!86.2  %𝐿!/𝑠 = 0.174𝑠 ∙ 1000𝑚𝑠 = 174  𝑚𝑠 
174 ms represents the duration of the shortening ramp (1.05-0.90 Lo) at 0.20 Vmax. 
The speed of each shortening ramp was expressed in two separate units: an absolute 
value, expressed in mm/s, or as a relative value, expressed as a percentage of maximum 
shortening velocity (% Vmax). 
3.8 Determining Active Force 
Active force is a complex function of sarcomere length, velocity, activation 
history, state of potentiation, and fatigue (Brown & Loeb, 1999). It is the contribution of 
the myofilaments to force production; found by changing muscle length while using 
electrical stimulation (Marsh, 1999). Whereas the passive tension of a muscle, found by 
changing the muscle length without stimulation, is the contribution of the series elastic 
components (e.g., tendons and cytoskeleton) to total force (Josephson, 1999). By 
separating the determinants of total tension, the contribution of potentiation to active 
tension can be analyzed. This was accomplished by subtracting passive tension from the 
total force trace record, leaving active force. 
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3.9 Determining Mean & Peak Force 
 Peak force was defined as the maximum tension the muscle produced in response 
to 100 Hz stimulation during shortening, measured in Millinewtons (mN); whereas mean 
force was defined as the sum of force over the shortening ramp divided by the number of 
scores. The mean and peak force during shortening provides insight into the physiological 
changes between the physical states of rest and potentiation, in particular with reference 
to RLC phosphorylation. Both values were normalized to specific tension for accurate 
comparison between genotypes.  
 Specific tension is acquired by dividing muscle mass by the product of muscle 
fiber length (mm) and muscle density (1.06g cm-3), as specified by Mendez and Keys 
(1960), as well as Brooks and Faulkner (1988), giving physiological cross-sectional area 
(PCSA). Specific tension is then given by dividing mean force by PCSA and expressed in 
(mN/ mm2).   
 Peak force during tetanic stimulation (CS) was used to assess fatigue (section 
3.12) and muscle viability throughout the experimental protocol.  
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3.10 Determining Rate of Force Development (+dF/dt) and Relaxation (-dF/dt) 
Rates of force development (+dF/dt) and force relaxation (-dF/dt) were calculated 
as the instantaneous rates of development and relaxation over the displacement during 
muscle shortening i.e., the integral of the active force record. The maximal responses of 
each contraction were taken and the means for each shortening velocity were pooled and 
compared according to genotype (WT vs. skMLCK-/-). In all cases, the use of relative 
values eliminated changes in muscle size, strength, and tissue viability and allowed for 
consistent evaluation between muscles and mouse genotypes.   
3.11 Determining Time to Peak Tension and Half Relaxation Time 
 Time to peak tension (TPT) was calculated as the time it took to reach peak force 
from the time active force production began during each shortening ramp (ms). Half 
relaxation time (½RT) was calculated as the time it took for force to diminish to 50 % of 
peak force levels (ms). The responses of each contraction were then collected and the 
means for each shortening velocity were pooled and compared according to genotype 
(WT vs. skMLCK-/-). 
3.11 Determining Work and Power 
Due to large differences in force output between genotypes work and power were 
normalized to muscle mass and scaled to Joules per kilogram (J kg-1) and Watts per 
kilogram (W kg-1). This was accomplished by taking the wet weight of each muscle post 
experimentally using an electronic balance and was expressed in milligrams (mg). Work 
done by the muscle was determined by calculating the average force over the distance of 
length change during each contraction (mN·m). Two methods were then used to calculate 
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Power output: multiplying mean force by shortening velocity and multiplying peak force 
by shortening velocity.  
3.12 Determining Potentiation and Fatigue 
Dividing the value of a contractile measure i.e., force, work, dF/dt, or power output 
when potentiated (post-CS) by the value of unpotentiated contractions (pre-CS) provided 
the relative difference (potentiation) for each contractile parameter.  
Comparing force output from the first tetanus of the first CS with the first tetanus 
of the last CS assessed fatigue (Grange et al., 1995). The value is given as a percentage of 
the initial maximal tetanic force. This measurement estimated relative muscle fatigue and 
ensured muscle viability throughout the experiment (Gittings et al., 2011). Any tetanic 
responses yielding less than 90% of the force from the initial tetanus were considered to 
be fatigued (Abbate et al., 2000) and any data collected during that experiment were not 
used for analysis (WT, n = 1). 
3.13 Myosin Phosphorylation Timeline 
A 2nd set of identical experiments were performed to measure the amount of 
phosphorylated RLC within the muscle at two time points within the protocol i.e., before 
and after the potentiating CS. Immediately following each event, the muscles were frozen 
by tongs precooled with liquid nitrogen and stored in microcentrifuge tubes at -80oC until 
analysis using urea-glycerol polyacrylamide gel electrophoresis.  
To ensure that changes in RLC phosphate content during the experimental protocol 
were due to the conditioning stimulus, and nothing else, the time points were strategically 
chosen as indicators of RLC phosphorylation. The first time point was taken after the CS 
to indicate that potentiation of force, work, and power is coincident with high levels of 
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RLC phosphorylation. The second was used as a baseline measure for RLC 
phosphorylation values corresponding to the state of the muscle at rest; taken 15 minutes 
post experiment. Selecting these two time points permitted biochemical samples to be 
collected within the same experiment as the collection of contractile data. This design 
reduced the number of mice used for the entire research project. 
 
  
 
 
 
 
 
 
 
Figure 8. The experimental timeline for collection of RLC phosphorylation content. Time point 1 
represents the peak of potentiation post CS (15 secs), whereas time point 2 represents the resting 
state of muscles during the experimental protocol. (n) Represents one EDL muscle; muscle 
selection for time-points (left vs. right) were randomized. 
3.14 Determining Myosin Phosphorylation Content 
The following is a brief overview of the methods used to determine myosin 
phosphorylation content (in mol phosphate per mol RLC) using the urea-glycerol PAGE 
western blot technique. For a detailed list of chemicals used and description of the 
methods see Appendix C: Western Blotting. 
 Muscles that were freeze-clamped during the experimental protocol were stored in 
the freezer (-80oC) and then were extracted from isolated microcentrifuge tubes, 
Biochemical Analysis 
CS 
Myosin Phosphorylation 
Timeline 
TIME 
Time point 1 Time point 2 
-15 secs 
0 
+15 secs 
15 mins 
Wildtype n = 4 
skMLCK n = 4 
  40 
denatured using dithiothreitol (DTT) and trichloroacetic acid (TCA), homogenized, and 
prepped for gel electrophoresis. Each muscle was homogenized by mortar and pestle 
(Wheaton, USA) until a consistent mixture was obtained. After centrifugation at 2000 
rpm for 2 minutes, the supernatant was poured off leaving a ‘pellet’. The remaining tissue 
pellet was then washed using ethyl ether to remove excess TCA. Following this, the 
pellet was resuspended in a urea based sample buffer and urea crystals were added, as 
necessary, to achieve complete saturation. After the RLC’s of each sample had been 
solubilized by urea the samples were pipetted into separate ‘wells’ of a BIO RAD minigel 
electrophoresis apparatus (10 µL per sample) containing a polyacrylamide gel with the 
addition of glycerol for density. Gels were run for 85 min at 400 V, and then 
electrophoretically transferred (60 min at 25 V) to a nitrocellulose membrane using a 
non-conducting gel-membrane cassette submerged in transfer buffer. After transfer, the 
membranes were washed with Tris buffered saline + Tween 20 (TBST), followed by 
incubation in blocking buffer for 1 hour to prevent blocking of non-specific protein 
binding. Lastly, the nitrocellulose gels were incubated with 1o (1:7500) antibody (RLC) 
and were then stored overnight at 4oC.  
The next day the membranes were washed with TBST to remove 1o antibody; 
immediately followed by incubation with 2o (1:10000) goat anti-rabbit IgG-horseradish 
peroxidase (Santa Cruz Biotechnology, Inc.) in TBST for 1 hour at room temperature. 
The membranes were then incubated with a detection buffer (enhanced 
chemiluminescence prime) for 3 minutes. Membranes were then rinsed with dH20, 
drained, and placed in a FLUORCHEM 5500 for exposure of the membrane and photo-
analysis of the blot. Each lane represented a different sample and was characterized by 
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three separate bands: non-phosphorylated RLC, an unknown band, and mono-
phosphorylated RLC. Sample content was quantified using ‘Image Studio Lite’ (Li-Core) 
western blotting software.  
3.15 Data Analysis and Statistics  
 The main purpose of the study was to investigate the effects of skMLCK gene 
ablation on peak power of mouse fast muscle. Several indicators of muscle performance 
were tested (mean and peak force, rate of force development/relaxation, time to peak 
tension, and work and power output) to provide a robust comparison between WT and 
skMLCK-/- mouse muscle. IBM SPSS Statistics analyzer, Version 21.0. was used to 
assess whether the data fit the Gaussian distribution (Shapiro Wilk test), as well as to 
examine measures of central tendency (skewness and kurtosis) and search for outliers; 
statistical analysis and hypothesis-significance testing were determined using Prism 6 
Graph Pad (La Jolla, CA). After examining the data for fit of the normal distribution, the 
results of the Shapiro Wilk test produced non-significant test results for each level of 
each of the independent variables. Therefore, no corrections were made to the data for 
analysis of parametric statistics. 
 For contractile experiments, a two-way factorial ANOVA (2x8) was used to 
examine the influence of shortening speed (0.05, 0.10, 0.20, 0.30, 0.35, 0.45, 0.55, & 
0.65 Vmax) and genotype (WT vs. skMLCK-/-) on the relative change in each of the 
contractile measures (force, contractile kinetics, work, and power).  
 Separate two-way ANOVAs tested the influence of shortening speed (0.05, 0.10, 
0.20, 0.30, 0.35, 0.45, 0.55, & 0.65 Vmax) and activation state (pre-CS vs. post-CS) on the 
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absolute change in each contractile measure (force, contractile kinetics, work, and 
power). This was repeated for each genotype i.e., WT and skMLCK-/-. 
 A two-way ANOVA was then used to examine the influence of genotype (WT vs. 
skMLCK-/-) and activation state (pre-CS vs. post-CS) on RLC phosphorylation content in 
mol/phos per mol/RLC.  
 All statistics are reported using means accompanied by standard error of the mean, 
when appropriate. A value will was considered significant if (p < .05). 
3.14.1 Sample Size Predictions 
 Based on a one-tailed test comparing the means for unpotentiated (M = 51.80 ± 
10.10) vs. potentiated (M = 68.10 ± 11.50) WT force values (n = 12) with a p value set to 
.05 and a power value of 0.9, the critical t-value was = 1.943, Df  = 6, giving a sample 
size of n = 4 (Gittings et al., 2012).  
RESULTS 
4.1 Animal Characteristics 
4.1.1   Body Mass 
 An unpaired t-test was conducted to determine if there were significant 
differences in body mass between mouse genotypes (WT vs. skMLCK-/-). The test 
revealed a significant increase in body mass for WT (27.56 ± 0.65 g, n = 10) compared to 
skMLCK-/- mice (23.25 ± 0.38 g, n = 10), [t = 5.74, df = 18, p < 0.0001, r2 = .65]. We 
normalized force to specific tension (mN·mm2) and work and power were normalized to 
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muscle mass (kg), therefore, we assumed mass differences did not impact the outcome 
measures. 
4.1.2   Muscle Mass 
 An unpaired t-test was conducted to determine if there were significant 
differences in muscle mass between genotypes (WT vs. skMLCK-/-). The test revealed a 
significant increase in muscle mass for WT (15.09 ± 0.91 g, n = 10) compared to 
skMLCK-/- muscles (11.82 ± 0.44 g, n = 10), [t = 3.25, df = 18, p = 0.0044, r2 = 0.37]. 
This result of this test was expected given the increase in body mass for WT mice. 
4.1.3   Muscle Length 
 An unpaired t-test was conducted to determine if any differences in muscle fiber 
length existed between genotypes (WT vs. skMLCK-/-). The test revealed that there were 
no significant differences in WT (10.78 ± 0.31) and skMLCK-/- muscles (10.70 ± 0.23), [t 
= 0.20, df = 18, p = 0.84, r2 = 0.002]. As a result, no further measures were taken to 
prevent confounding variables. 
4.1.4   PCSA 
 An unpaired t-test was conducted to determine if any differences in muscle fiber 
physiological cross-sectional area were present between the two genotypes (WT vs. 
skMLCK-/-). The tests revealed that WT muscles had significantly larger PCSA values 
(1.33 ± 0.09) than skMLCK-/- muscles (1.04 ± 0.05), [t = 2.86, df = 18, p = 0.01, r2 = 
0.31]. This difference was expected considering that PCSA is a function of muscle mass 
(mg) divided by the product of mammalian muscle density 1.06mg mm-3 and muscle 
fiber length (mm). No follow up measures were required. 
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4.1.5   Age 
 An unpaired t-test was conducted to determine if there were significant 
differences in age between genotypes (WT vs. skMLCK-/-). The test revealed that WT 
mice were significantly older (143.5 ± 6.18 days) than skMLCK-/- mice (91.40 ± 15.34 
days), [t = 3.15, df = 18, p = 0.006, r2 = 0.36].  
4.2 Contractile Measures 
4.2.1    Relative Concentric Force Potentiation 
 A two-way ANOVA was conducted to assess the effects of shortening velocity 
(0.05, 0.10, 0.20, 0.30, 0.35, 0.45, 0.55, & 0.65 Vmax) and genotype (WT vs. skMLCK-/-) 
on the relative change in concentric force after a tetanic conditioning stimulus (CS). 
Results revealed significant main effects for velocity, [F (7, 144) = 20.98, p < 0.0001, n2 
= .41] and for genotype, [F (1, 144) = 68.93, p < 0.0001, n2 = 0.19] on force. Post-hoc 
tests (Holm-Sidak) were then conducted to reveal the differences in force between 
genotypes, among levels of shortening velocity. WT force values were found to be 
significantly higher than skMLCK-/- at all shortening velocities when compared at the 
same velocity (p < 0.05).  
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Figure 9. Relative concentric force (post-CS/ pre-CS) of mouse EDL at different shortening 
velocities (%Vmax), after tetanic stimulation (CS). * Indicates significant difference from 
skMLCK-/- value at the same velocity, (p < 0.05); § (p < .01). Values are presented as means and 
± SEM (n = 10). 
 
4.2.2 Absolute Concentric Force Potentiation 
 A two-way RM ANOVA was conducted for each genotype to test the effects of 
shortening velocity (0.05, 0.10, 0.20, 0.30, 0.35, 0.45, 0.55, & 0.65 Vmax) and activation 
state (pre-CS vs. post-CS) on concentric force. Results for WT revealed a significant 
interaction effect and [F, (7, 63) = 4.611, p = 0.0003, n2 = 0.005] significant main effects 
for shortening velocity [F (7, 63) = 91.78, p < 0.0001, n2 = 0.56] and for activation state 
[F (1, 9) = 48.90, p < 0.0001, n2 = 0.062] on concentric force. Post-hoc comparisons 
(Holm-Sidak) revealed that forces post-CS were significantly higher than pre-CS values 
when compared at the same velocity (p < 0.001), furthermore, this increase was greater at 
shortening speeds above 0.05 Vmax (p < 0.0001).  
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 Results for skMLCK-/- revealed a significant interaction effect [F, (7, 63) = 14.45, 
p < 0.0001, n2 = 0.02] and significant main effects for shortening velocity [F (7, 63) = 
99.38, p < 0.0001, n2 = 0.55] on concentric force. Post-hoc comparisons (Holm-Sidak) 
revealed that post-CS forces were significantly higher than pre-CS, at shortening 
velocities 0.30 Vmax and above (p < 0.01), however, at 0.20 Vmax there was no significant 
change in force between conditions (t = 0.8028, p > 0.05). At slow shortening velocities 
of 0.05 (p < 0.0001) and 0.10 Vmax (p < 0.01) there was a significant decrease in force 
post-CS.  
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Figure 10. Specific Tension of WT mouse EDL muscle at different shortening velocities 
(%Vmax), before (solid line) and after (dashed line) tetanic stimulation (CS). † Indicates 
significant difference from pre-CS value at same velocity, (p < 0.001); ‡, (p < 0.0001). Values are 
presented as means and ± SEM (n = 10). 
 
 
 
 
 
 
 
 
Figure 11. Specific tension of skMLCK-/- mouse EDL muscle at different shortening velocities 
(%Vmax), before (solid line) and after (dashed line) tetanic stimulation (CS). § Indicates 
significant difference from Pre-CS value at the same velocity, (p < 0.01); †, (p < 0.001); ‡, (p < 
0.0001). Values are presented as means and ± SEM (n = 10).
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4.2.3    Relative Contractile Kinetics 
 Separate two-way ANOVAs were conducted to assess the effects of shortening 
velocity (0.05, 0.10, 0.20, 0.30, 0.35, 0.45, 0.55, & 0.65 Vmax) and genotype (WT vs. 
skMLCK-/-) on the relative change in rate of force development (+dF/dt) and rate of force 
relaxation (-dF/dt). Results for +dF/dt revealed a main effect for genotype [F, (7, 144) = 
94.34, p < 0.0001, n2 = 0.38] on the maximum rate of force development. Sidak’s 
comparison revealed that WT values were significantly higher than skMLCK-/- at all 
shortening velocities, when compared at the same shortening velocity, (p < 0.05). Results 
for -dF/dt revealed a main effect for velocity [F, (7, 144) = 40.97, p < 0.0001, n2 = 0.65]; 
however, no effect for genotype was present (p = 0.8011) and therefore no post-hoc tests 
were conducted. 
4.2.4    Absolute Contractile Kinetics  
 A two-way RM ANOVA was conducted for each genotype to test the effects of 
shortening velocity (0.05, 0.10, 0.20, 0.30, 0.35, 0.45, 0.55, & 0.65 Vmax) and activation 
state (pre-CS vs. post-CS) on the maximum rate of force development (+dF/dt). Separate 
two-way ANOVAs were then conducted for the rate of relaxation (-dF/dt). Results for 
(+dF/dt) in WT revealed a significant interaction effect [F, (7, 63) = 10.37, p < 0.0001, n2 
= .002], a main effect for velocity [F, (7, 63) = 64.43, p < 0.0001, n2 = 0.17], and a main 
effect for activation state [F, (1, 9) = 87.09, p < 0.0001, n2 = 0.37] on the rate of force 
development. As a result, post-hoc tests (Holm-Sidak) were conducted to compare pre-
CS and post-CS values at each shortening velocity. The tests revealed a significant 
increase in +dF/dt after the CS, at every shortening velocity, (p < 0.0001).  
  50 
 Results for (+dF/dt) in skMLCK-/- revealed a significant interaction [F, (7, 63) = 
2.355, p = 0.033, n2 = 0.002] and significant main effects for shortening velocity [F, (7, 
63) = 77.10, p < 0.0001, n2 = 0.33] and for activation state [F, (1, 9) = 69.43, p < 0.0001, 
n2 = 0.04]. Post-hoc tests (Holm-Sidak) were conducted to reveal the differences in 
(+dF/dt) between genotypes, among levels of shortening velocity. The tests revealed a 
significant increase in +dF/dt after the CS, at every shortening velocity, p < .0001.  
 Results for -dF/dt in WT revealed a significant a significant interaction effect [F, 
(7, 63) = 21.76, p < 0.0001, n2 = 0.06] and significant main effects for velocity [F (7, 63) 
= 51.28, p < 0.0001, n2 = 0.35] and for activation state [F (1, 9) = 45.51, p < 0.0001, n2 = 
0.12] on the rate of force relaxation. As a result, post-hoc tests (Holm-Sidak) were 
conducted to compare pre-CS and post-CS values at each shortening velocity. The tests 
revealed a significant increase in -dF/dt after the CS, between shortening velocities of 
0.05-0.30 Vmax, (p < 0.0001); a significant increase was also seen at 0.35 Vmax, (p < 0.05). 
 Results of the ANOVA for -dF/dt in skMLCK-/- revealed a significant interaction 
effect [F, (7, 63) = 22.08, p < 0.0001, n2 = 0.07] and significant main effects for velocity 
[F, (7, 63) = 22.64, p < 0.0001, n2 = 0.23] and activation state [F (1, 9) = 29.83, p = 0.12, 
n2 = 0.13] on the rate of force relaxation. As a result, post-hoc tests (Holm-Sidak) were 
conducted to compare pre-CS and post-CS values at each shortening velocity. The tests 
revealed a significant increase in -dF/dt after stimulation, between shortening velocities 
of 0.05-0.30 Vmax, (p < 0.0001); a significant increase was also seen at 0.35 Vmax, (p < 
0.05). A summary of results for contractile kinetics is expressed in Tables 1 and 2.  
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12. A) Relative change (post-CS/ pre-CS) in maximum rate of force development (+dF/dt) and B) 
maximum rate of force relaxation of mouse EDL in WT and skMLCK-/- mice after tetanic 
stimulation (CS). Values are presented as means and ± SEM for each velocity (n = 10). A) * 
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4.2.5    Gross Changes in Contractile Kinetics  
 In order to display the overall effect of genotype (WT vs. skMLCK-/-) and 
activation state (pre-CS vs. post-CS) on +dF/dt and -dF/dt irrespective of shortening 
velocity, a two-way RM ANOVA was conducted for each measure. The results of the 
ANOVA for +dF/dt revealed a significant interaction effect [F, (1, 14) = 31.29, p < 
0.0001, n2 = 0.01] and main effect for activation state [F, (1, 14) = 389.90, p < 0.0001, n2 
= 0.17]. Post-hoc tests (Holm-Sidak) were then conducted to examine the differences 
between genotypes and activation state. The results revealed significant increases in 
+dF/dt after the CS in WT and skMLCK-/- mice, p < .0001. No differences between 
genotypes were present pre-CS (t = 0.1906, p > 0.05) or post-CS (t = 0.7841, p > 0.05). 
 The results for -dF/dt revealed a significant main effect for activation state [F, (1, 
14) = 26.04, p < 0.0002, n2 = 0.21]. Post-hoc tests (Holm-Sidak) were then conducted to 
examine the differences between pre-CS and post-CS. The results revealed significant 
increases in -dF/dt after the CS, (p < 0.01). No differences between genotypes were 
present pre-CS (t = 1.451, p < 0.05) or post-CS (t = 1.863, p < 0.05). 
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Figure 13. The maximum rate of force development (+dF/dt) in WT and skMLCK-/- mice when 
collapsed for shortening velocity. Values are presented as pooled means and ± SEM (n = 10). ‡ 
Indicates a significant difference between pre-CS and post-CS, (p < 0.0001).  
 
 
 
 
 
 
 
 
 
Figure 14. The maximum rate of force relaxation (-dF/dt) in WT and skMLCK-/- mice when 
collapsed for shortening velocity. Values are presented as means and ± SEM (n = 10). § Indicates 
a significant difference between pre-CS and post-CS, (p < 0.01). 
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4.2.6    Relative Time to Peak Tension 
 A two-way ANOVA was conducted to assess the effects of shortening velocity  
(0.05, 0.10, 0.20, 0.30, 0.35, 0.45, 0.55, & 0.65 Vmax) and genotype (WT vs. skMLCK-/-) 
on the relative change in time to peak tension (TPT) for each muscle. The ANOVA 
revealed significant main effects for shortening velocity [F (7, 144) = 31.89, p < 0.0001, 
n2 = 0.54] and for genotype [F (1, 144) = 35.77, p < 0.0001, n2 = 0.09] on TPT. Post-hoc 
tests were then conducted to reveal differences in TPT, between genotypes, among levels 
of shortening velocity. Using Holm-Sidak’s Test, WT values were found to take 
significantly longer to reach peak than skMLCK-/- at 0.20 Vmax (p < 0.001) and 0.35 Vmax 
(p < 0.01). 
 
 
 
 
 
 
 
 
 
 
Figure 15. Relative change (post-CS/ pre-CS) in time to peak tension (TPT) of mouse EDL in 
WT and skMLCK-/- mice after tetanic stimulation (CS). Values are presented as means and ± 
SEM for each velocity (n = 10). § Indicates a significant difference between pre-CS and post-CS, 
p < .01; †, p < .001. 
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4.2.7    Absolute Time to Peak Tension  
 A two-way RM ANOVA was conducted for each genotype to assess the effects of 
shortening velocity (0.05, 0.10, 0.20, 0.30, 0.35, 0.45, 0.55, & 0.65 Vmax) and activation 
state (pre-CS vs. post-CS) on absolute TPT. Results of the ANOVA for WT revealed a 
significant interaction [F (7, 63) = 30.70, p < 0.0001, n2 = 0.02] and significant main 
effects for velocity, [F (7, 63) = 994.3, p < 0.0001, n2 = 0.88] and for activation state, [F 
(1, 9) = 28.77, p = 0.0005, n2 = 0.08] on TPT. Post-hoc tests (Holm-Sidak) revealed a 
significant increase in TPT pre-CS compared with post-CS at 0.05 (p < 0.001) and 0.10 
Vmax  (p < 0.05). For shortening velocities between 0.20-0.65 Vmax, post-CS values were 
significantly higher than Pre-CS (p < 0.0001). 
 The ANOVA for skMLCK-/- revealed a significant interaction [F (7, 63) = 20.23, 
p < .0001, n2 = 0.03] and a significant main effect for velocity, [F (7, 63) = 422.3, p < 
0.0001, n2 = 0.92] on TPT. Post-hoc tests (Holm-Sidak) revealed a significant increase in 
TPT pre-CS compared with post-CS values at shortening velocities of 0.05 (p < 0.0001) 
and 0.10 Vmax (p < 0.01). On the other hand, at 0.45 and 0.65 Vmax, post-CS TPT was 
significantly longer than pre-CS (p < 0.01, p < 0.05, respectively). 
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4.2.8    Relative Half Relaxation Time  (½RT)  
 A two-way ANOVA was conducted to assess the effects of shortening velocity 
(0.05, 0.10, 0.20, 0.30, 0.35, 0.45, 0.55, & 0.65 Vmax) and genotype (WT vs. skMLCK-/-) 
on the relative change in ½RT after a tetanic conditioning stimulus (CS). Results revealed 
a significant interaction [F (7, 144) = 2.082, p = 0.0491, n2 = 0.01] and significant main 
effects for velocity, [F (7, 144) = 119.2, p < 0.0001, n2 = 0.75] and for genotype, [F (1, 
144) = 122.3, p < 0.0001, n2 = 0.11] on ½RT.  Post-Hoc tests revealed significantly 
longer ½RT for WT than skMLCK-/- muscles at 0.05 (p < 0.0001), 0.10 (p < 0.01), 0.30 
(p < 0.01), 0.45 (p < 0.0001), 0.55 (p < 0.0001), and 0.65 Vmax (p < 0.0001).   
 
 
 
 
 
 
 
 
 
 
Figure 16. Relative change (post-CS/ pre-CS) in half relaxation time (½RT) of mouse EDL in 
WT and skMLCK-/- mice after tetanic stimulation (CS). Values are presented as means and ± 
SEM for each velocity (n = 10). § Indicates a significant difference between pre-CS and post-CS, 
(p < 0.01); ‡, (p < 0.001). 
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4.2.9    Absolute Half Relaxation Time 
 A two-way RM ANOVA was conducted for each genotype to assess the effects of 
shortening velocity (0.05, 0.10, 0.20, 0.30, 0.35, 0.45, 0.55, & 0.65 Vmax) and activation 
state (pre-CS vs. post-CS) on absolute ½RT. Results of the ANOVA for WT revealed a 
significant interaction [F (7, 63) = 58.12, p < 0.0001, n2 = 0.16] and significant main 
effects for velocity, [F (7, 63) = 101.5, p < 0.0001, n2 = 0.68] and for activation state, [F 
(1, 9) = 11.30, p = 0.0084, n2 = 0.01] on ½RT. Post-hoc tests (Holm-Sidak) revealed a 
significant increase in ½RT pre-CS compared with post-CS for 0.05-0.20 Vmax (p < 
0.0001); no significant differences were seen between conditions at 0.30 Vmax (t = 0.455, 
p < 0.05). On the other hand, at 0.35 Vmax, post-CS ½RT was significantly longer than 
pre-CS values (p < 0.05), and between 0.45-0.65 Vmax (p < 0.0001). 
  The ANOVA for skMLCK-/- revealed a significant interaction [F (7, 63) = 108.4, 
p < 0.0001, n2 = 0.19] and a significant main effect for velocity, [F (7, 63) = 75.59, p < 
0.0001, n2 = 0.55] and activation state [F (1, 9) = 266.1, p < 0.0001, n2 = 0.12] on ½RT. 
Post-hoc-tests (Holm-Sidak) revealed a significant increase in ½RT pre-CS compared 
with post-CS values at shortening velocities between 0.05-0.30 Vmax (p < 0.0001). 
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4.2.10    Relative Muscle Work  
 A two-way ANOVA was conducted to assess the effects of shortening velocity 
(0.05, 0.10, 0.20, 0.30, 0.35, 0.45, 0.55, & 0.65 Vmax) and genotype (WT vs. skMLCK-/-) 
on the relative change in muscle work after a tetanic conditioning stimulus (CS). Results 
revealed significant main effects for velocity, [F (7, 144) = 71.49, p < 0.0001, n2 = 0.55] 
and for genotype, [F (1, 144) = 260.2, p < 0.0001, n2 = 0.28] on work. Post-hoc tests were 
then conducted to reveal the differences in work, between genotypes, among levels of 
shortening velocity. Using Holm-Sidak’s test, WT work values were found to be 
significantly higher than skMLCK-/- at all shortening velocities when compared at the 
same velocity, (p < .0001); with the exception of 0.10 Vmax (p < 0.05). All shortening 
velocities were then compared to the slowest shortening velocity (0.05 Vmax) of each 
genotype (WT & skMLCK-/-) to examine the differences in speed within genotypes. 
Results of the tests (Holm-Sidak) revealed a significant difference in WT muscles 
between 0.05 Vmax and all shortening velocities (p < 0.01), except at 0.10 Vmax (p = 
0.8393); however the relative change was still higher than at 0.05 Vmax (1.04 vs. 1.00). 
 In skMLCK-/- muscles, every shortening velocity was found to be significantly 
different from 0.05 Vmax (p < 0.05). The largest relative difference in each genotype was 
trending towards 0.65 Vmax (WT, 1.53%; skMLCK-/-, 1.20%).  
  63 
 
 
 
 
 
 
 
 
 
Figure 17. Relative work output (post-CS/ pre-CS) of EDL in WT and skMLCK-/- mice. Values 
are presented as means and ± SEM (n = 10). Red dashed line indicates maximal pre-CS work 
output for each velocity. § Indicates significant increase in WT work output above skMLCK-/-, (p 
< 0.01); ‡, (p < 0.0001).  
 
4.2.11    Absolute Muscle Work 
 A two-way RM ANOVA was conducted for each genotype to assess the effects of 
shortening velocity (0.05, 0.10, 0.20, 0.30, 0.35, 0.45, 0.55, & 0.65 Vmax) and activation 
state (pre-CS vs. post-CS) on absolute muscle work. Results of the ANOVA for WT 
revealed a significant interaction [F (7, 63) = 83.68, (p < 0.0001), n2 = 0.05] and 
significant main effects for velocity, [F (7, 63) = 128.7, p < 0.0001, n2 = 0.49] and for 
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when compared at the same velocity, (p < 0.0001). At 0.05 and 0.10 Vmax there were no 
significant changes between activation states, t = 0.073 and t = 1.137, respectively (p > 
0.05). 
 Results for skMLCK-/- revealed a significant interaction [F (7, 63) = 33.04, p < 
0.0001, n2 = 0.03] and significant main effects for velocity, [F (7, 63) = 86.78, p < 
0.0001, n2 = 0.52] and for activation state, [F (1, 9) = 11.57, p = 0.0079, n2 = 0.005] on 
work. Post-hoc tests (Holm-Sidak) revealed that muscle work at shortening velocities 
between 0.05-0.20 Vmax were significantly higher pre-CS than post-CS, (p < 0.001). At 
0.30 Vmax there was a crossover effect such that post-CS values were significantly higher 
than pre-CS, (p < 0.05), and this difference increased at 0.35 Vmax and above, (p < 
0.0001).  
 
Figure 18. A) Absolute work output in WT and B) in skMLCK-/- muscles, expressed in Joules per 
Kilogram of muscle mass. Values are presented as means and ± SEM for each shortening 
velocity. * Indicates significant difference from other condition (pre-CS vs. post-CS), (p < 0.05); 
† significant difference (p < 0.001); ‡ Significant difference (p < 0.0001).  
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4.2.12    Absolute Mean Power Output 
 A two-way RM ANOVA was conducted to test the hypothesis that WT muscles 
would produce higher concentric power output after the conditioning stimulus. To assess 
this outcome we analyzed the influence of shortening velocity (0.05, 0.10, 0.20, 0.30, 
0.35, 0.45, 0.55, & 0.65 Vmax) and activation state (pre-CS vs. post-CS) on concentric 
power output. Results for WT revealed a significant interaction effect and [F, (7, 63) = 
31.04, p = 0.0003, n2 = 0.027] significant main effects for shortening velocity [F (7, 63) = 
132.7, p < 0.0001, n2 = 0.64] and for activation state [F (1, 9) = 76.06, p < 0.0001, n2 = 
0.07]. Post-hoc comparisons (Holm-Sidak) revealed that post-CS values were 
significantly higher than pre-CS at 0.20 Vmax (p < .001) and at 0.30 Vmax and above (p < 
0.0001), when compared at the same velocity. Furthermore, post-hoc tests were 
conducted to examine differences in shortening velocity post-CS. Slower speeds of 
shortening (0.05-0.30 Vmax) produced significantly lower power output than faster 
velocities of shortening (0.35-0.65 Vmax, p < 0.0001). However, no discernible peak in 
power was observed between 0.35-0.65 Vmax.  
 Results for skMLCK-/- revealed a significant interaction effect [F, (7, 63) = 26.77, 
p < 0.0001, n2 = 0.02] and significant main effects for shortening velocity [F (7, 63) = 
115.7, p < 0.0001, n2 = 0.68] and activation state [F (1, 9) = 45.74, p < 0.0001, n2 = 0.02]. 
Post-hoc comparisons (Holm-Sidak) revealed that post-CS values were significantly 
higher than pre-CS at shortening velocities 0.30 Vmax and above (p < 0.0001). 
Furthermore, post-hoc tests were conducted to examine differences in shortening velocity 
post-CS. Slower speeds of shortening (0.05-0.35 Vmax) produced significantly lower 
power output than faster velocities of shortening (0.45-0.65 Vmax, p < 0.05). However, no 
  66 
discernible peak in power was observed between 0.45-0.65 Vmax and seemed to display a 
plateau.  
 
Figure 19. A) Absolute mean power output in WT and B) in skMLCK-/- muscles, expressed in 
Watts per Kilogram of muscle mass. Values are presented as means and ± SEM for each 
shortening velocity. † Indicates significant difference from other condition (pre-CS vs. post-CS), 
(p < 0.001); ‡ significant difference (p < 0.0001). 
 
 
 
 
 
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7
0
10
20
30
Relative Shortening Velocity
 P
ow
er
 (W
at
ts
 k
g-
1 )
WT Pre-CS WT Post-CS
†
‡
‡
‡‡‡
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7
0
10
20
30
Relative Shortening Velocity
Po
w
er
 (W
at
ts
 k
g-
1 )
skMLCK-/- Pre-CS skMLCK-/- Post-CS
‡
‡
‡
‡ ‡
A B
  67 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T
ab
le
 6
. M
ea
n 
po
w
er
 o
ut
pu
t o
f m
ou
se
 E
D
L 
in
 W
T 
an
d 
sk
M
LC
K
-/-
 m
ic
e.
 
!!
!!
!
  
  
  
!!
!!
0.
05
 V
m
ax
 
0.
10
 V
m
ax
 
0.
20
 V
m
ax
 
0.
30
 V
m
ax
 
0.
35
 V
m
ax
 
0.
45
 V
m
ax
 
0.
55
 V
m
ax
 
0.
65
 V
m
ax
 
!!
!!
  
  
  
  
  
  
  
  
B
ef
or
e 
sk
M
LC
K
-/-
 
4.
40
 ±
 0
.3
7 
8.
17
 ±
 0
.7
0 
13
.7
8 
± 
1.
20
 
16
.9
1 
± 
1.
45
 
19
.5
9 
± 
1.
60
 
20
.9
8 
± 
1.
57
 
20
.7
3 
± 
1.
65
 
20
.4
8 
± 
1.
76
 
W
T 
4.
32
 ±
 0
.3
2 
7.
59
 ±
 0
.6
8 
13
.0
6 
± 
0.
94
 
16
.4
2 
± 
1.
31
 
19
.0
3 
± 
1.
63
 
19
.6
8 
± 
1.
40
 
19
.4
7 
± 
1.
55
 
19
.2
5 
± 
1.
74
 
  
  
 
 
 
 
 
 
 
 
A
fte
r 
sk
M
LC
K
-/-
 
3.
94
 ±
 0
.2
8 
7.
63
 ±
 0
.6
8 
14
.1
1 
± 
1.
02
 
19
.4
3 
± 
1.
61
‡ 
23
.6
2 
± 
1.
81
‡ 
25
.1
0 
± 
1.
89
‡ 
25
.2
9 
± 
2.
07
‡ 
25
.4
8 
± 
2.
26
‡ 
W
T 
4.
63
 ±
 0
.3
8 
8.
36
 ±
 0
.7
7 
15
.4
0 
± 
1.
24
† 
21
.5
9 
± 
1.
53
‡ 
25
.5
3 
± 
1.
90
‡ 
27
.3
9 
± 
2.
00
‡ 
26
.9
4 
± 
2.
15
‡ 
26
.4
9 
± 
2.
39
‡ 
  
  
 
 
 
 
 
 
 
 
R
el
at
iv
e 
sk
M
LC
K
-/-
 
0.
91
± 
0.
04
 
0.
94
 ±
 0
.0
3 
1.
04
 ±
 0
.0
4 
1.
16
 ±
 0
.0
4 
1.
21
 ±
 0
.0
3 
1.
20
 ±
 0
.0
2 
1.
22
 ±
 0
.0
2 
1.
24
 ±
 0
.0
4 
W
T 
1.
07
 ±
 0
.0
4*
 
1.
11
 ±
 0
.0
5*
 
1.
18
 ±
 0
.0
2 
1.
33
 ±
 0
.0
3*
 
1.
37
 +
 0
.0
5 
1.
39
 ±
 0
.0
4§
 
1.
39
 ±
 0
.0
4*
 
1.
39
 ±
 0
.0
7 
N
ot
e:
 P
ow
er
 o
ut
pu
t i
s 
ex
pr
es
se
d 
as
 W
 k
g-
1 . 
V
al
ue
s 
ar
e 
pr
es
en
te
d 
as
 m
ea
ns
 a
nd
 ±
 S
EM
 (n
 =
 1
0)
. R
el
at
iv
e 
ch
an
ge
 is
 c
al
cu
la
te
d 
as
 p
os
t-C
S 
(A
fte
r)
 
va
lu
e 
di
vi
de
d 
by
 p
re
-C
S 
va
lu
e 
(B
ef
or
e)
. M
us
cl
es
 w
er
e 
st
im
ul
at
ed
 w
ith
 2
 p
ul
se
s. 
 
  
A
fte
r:
 *
 In
di
ca
te
s a
 si
gn
ifi
ca
nt
 in
cr
ea
se
 a
bo
ve
 p
re
-C
S 
va
lu
es
, (
p 
< 
0.
05
); 
‡ 
(p
 <
 0
.0
00
1)
. 
 
R
el
at
iv
e:
 *
 In
di
ca
te
s a
 si
gn
ifi
ca
nt
 in
cr
ea
se
 a
bo
ve
 sk
M
LC
K
-/-
 v
al
ue
s, 
(p
 <
 0
.0
5)
; §
 (p
 <
 0
.0
1)
. 
  68 
4.2.13    Absolute Peak Power Output 
  A two-way RM ANOVA was conducted for each genotype to test the effects of 
shortening velocity (0.05, 0.10, 0.20, 0.30, 0.35, 0.45, 0.55, & 0.65 Vmax) and activation 
state (pre-CS vs. post-CS) on concentric power output, calculated from peak as opposed 
to mean force. Results for WT revealed a significant interaction effect and [F, (7, 63) = 
73.19, p < 0.0001, n2 = 0.01] significant main effects for shortening velocity [F (7, 63) = 
179.10, p < 0.0001, n2 = 0.62] and for activation state [F (1, 9) = 107.00, p < 0.0001, n2 = 
0.08]. Post-hoc comparisons (Holm-Sidak) revealed that post-CS values were 
significantly higher than pre-CS at every shortening velocity (p < 0.0001), when 
compared at the same velocity. Furthermore, post-hoc tests (Holm-Sidak) were conducted 
to examine differences in shortening velocity within conditions. For post-CS values, it 
was found that at 0.45 Vmax significantly higher power output was produced compared 
with any other velocities of shortening (p < 0.001). However, for pre-CS values the 
velocity corresponding to peak power was the same (0.45 Vmax) and therefore no shift 
was evident.  
 Results for skMLCK-/- revealed a significant interaction effect [F, (7, 63) = 13.65, 
p < 0.0001, n2 = 0.003] and significant main effects for shortening velocity [F (7, 63) = 
105.5, p < 0.0001, n2 = 0.57] and activation state [F (1, 9) = 36.12, p = 0.0002, n2 = 0.02]. 
Post-hoc comparisons (Holm-Sidak) revealed that post-CS values were significantly 
higher than pre-CS at 0.10 Vmax (p < 0.001) and a greater difference at 0.20 Vmax and 
above (p < 0.0001), when compared at the same velocity. Furthermore, post-hoc tests 
(Holm-Sidak) were conducted to examine differences in shortening velocity within 
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conditions. It was found that no velocity corresponded to peak power in either condition 
(p > 0.05) once again displaying a plateau. 
 
Figure 20. A) Absolute peak power output in WT and B) in skMLCK-/- muscles, expressed in 
Watts per Kilogram of muscle mass. Values are presented as means and ± SEM for each 
shortening velocity. † Indicates significant difference from other condition (pre-CS vs. post-CS), 
(p < 0.001); ‡ significant difference (p < 0.0001). 
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4.2.14    Power Curve Fitting 
 A second order polynomial (quadratic) was fit to the data of each condition (pre-
CS vs. post-CS) for each genotype (WT & skMLCK-/-) for both mean and peak power. 
The equation describing the curve i.e., y = a(x2) + b(x) + c was used to extrapolate the 
curve by solving for a given x value. As shown in figure 23, x values were extrapolated 
for 0.75, 0.85, and 0.95 Vmax. The equation was then used to find the peak of each curve 
to create a better estimate of the corresponding x value (% Vmax) defining peak power. 
For mean power, the shortening velocities that corresponded to peak power output in WT 
were 0.53 & 0.56 Vmax and in skMLCK-/- were 0.52 & 0.54 Vmax for pre-CS and post-CS 
conditions, respectively. For peak power, the shortening velocities that corresponded to 
peak power output in WT were 0.47 & 0.48 Vmax and in skMLCK-/- were 0.48 & 0.48 
Vmax for pre-CS and post-CS conditions, respectively. All curves were fit from mean data 
and the polynomial fits were not tested for normality or confidence intervals. Therefore, 
we cannot truly claim if a shift in velocity did occur for peak power; regardless, the data 
and curve fittings suggest no shift was evident. The following equations represent the 
best fit curves for the data in the panels shown below: A) y = -72.976x2 + 75.193x + 
0.8223 (pre-CS) and y = -100.15x2 + 107.35x - 1.0883 (post-CS) B) y = -73.361x2 + 
77.253x + 0.9756 (pre-CS) and y = -85.845x2 + 96.266x - 1.019 (post-CS) C) y = -
214.94x2 + 201.61x + 4.1852 (pre-CS) and y = -268.96x2 + 260.02x + 4.0126 (post-CS) 
D) y = -189.6x2 + 180.69x + 3.2818 (pre-CS) and y = -215.02x2 + 207.67x + 2.895 (post-
CS). 
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Figure 21. Four panel diagram displaying hypothetical curves for power output. A) Mean power 
in WT and B) skMLCK-/- muscles, C) Peak power in WT and D) skMLCK-/- muscles. Data points 
from 0.05-0.65 Vmax represent means (n = 10) and all data to the right of the dashed line represent 
extrapolated hypothetical data. Curves are best fit to the data using non-linear regression (second 
order polynomial). 
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4.3 Biochemical Data 
4.3.1   RLC Phosphorylation Content 
 A two-way ANOVA was conducted to assess the effects of genotype (WT vs. skMLCK-
/-) and activation state (pre-CS vs. post-CS) on myosin phosphorylation content of mouse 
EDL muscle. Results of the ANOVA revealed a significant interaction [F (1, 12) = 74.54, 
p < 0.0001, n2 = 0.23] and significant main effects for genotype, [F (1, 12) = 106.70, p < 
0.0001, n2 = 0.37] and for activation state, [F (1, 12) = 113.10, p < 0.0001, n2 = 0.37] on 
total phosphorylation content. Post-hoc tests were then conducted to reveal the 
differences between genotypes at rest and after stimulation. The tests (Holm-Sidak) 
revealed that RLC phosphorylation in WT were significantly higher after stimulation 
(0.63) than at rest (0.08 mol P/mol RLC), (p < 0.0001). skMLCK-/- mice had no 
significant changes in RLC phosphate content between rest and after stimulation (p > 
0.05). 
Note: RLC phosphate content expressed in mol P/mol RLC. Muscles were frozen at only one 
time point i.e., resting or after stimulation. Values are presented as means and ± SEM (n = 4).  
   a Indicates a significant difference from other letters 
  b Indicates a significant difference from other letters 
 
 
 
 
 
Table 8. RLC phosphate content of mouse EDL in WT and skMLCK-/- mice. 
GENOTYPE  
	  
               CONDITION   
	  	   	  	   RESTING STIMULATED 
	  	   	  	           WT   0.08 ± 0.01ª 0.63 ± 0.06b 
           skMLCK-/-   0.03 ± 0.01ª 0.08 ± 0.01ª 
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Figure 22. A) Representative Urea/Glycerol PAGE blot of monophosphorylated and non-
phosphorylated myosin RLC from individual WT and skMLCK-/- mouse EDL muscle. B) RLC 
phosphate content in mouse EDL at rest (open bars) and after stimulation (black bars). Muscles 
were frozen in liquid nitrogen immediately after the CS or after 15 minutes of quiescence. Values 
are presented as mean and ± SEM (n = 4). ‡ Indicates significant difference from all other 
conditions. 
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4.4 Viability of muscle preparations  
4.4.1   Assessment of Tetanic Force 
 Isometric tetanic force (Po) was measured during successive conditioning stimuli 
(CS) to provide information about the viability of the muscle preparation for each muscle 
(n = 10). The WT force from the first tetanus of the CS was altered by only 2% between 
the first and last protocol (218.55 ± 22.41 to 220.55 ± 21.51 mN, respectively) and 
changed by only 5% in skMLCK-/- muscles (184.28 ± 14.44 to 192.57 ± 11.94 mN, 
respectively). These results indicate that the muscle preparations had not significantly 
fatigued or been damaged by previous stimulation, as proposed by Barclay, (2005). 
 DISCUSSION 
5.1   General Discussion 
 The purpose of the current study was to determine the contribution of RLC 
phosphorylation on peak power of mouse EDL muscle. This was accomplished by 
comparing the mechanical output of WT and skMLCK-/- muscles, at rest and after tetanic 
stimulation, over a wide range of shortening velocities (0.05-0.65 Vmax). Our secondary 
purpose was to investigate whether stimulation induced increases in RLC 
phosphorylation would positively impact the force-velocity properties of WT-EDL 
muscles, effectively increasing the velocity at which peak power occurs.  
 The skMLCK gene knockout provides a negative control to WT muscles since it 
does not display any stimulation induced RLC phosphorylation (Zhi et al., 2005; Gittings 
et al., 2011; 2014) Therefore, the contribution of RLC phosphorylation to force, work and 
power can be parsed out by subtracting post-CS skMLCK-/- values from that of post-CS 
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WT values, leaving the force contribution attributable to RLC phosphorylation. The 
proposed mechanism for phosphorylation mediated force potentiation is covalent binding 
of a negatively charged phosphate moiety to the RLC of myosin which propels the 
myosin head away from the thick filament backbone and towards actin (Alamo et al., 
2008; Brito et al., 2011; Padron et al., 1991). The closer proximity of myosin to actin 
increases the rate of crossbridge attachment (fapp) leading to an increased fraction of 
cycling crossbridges in the strongly bound force generating state (aFS) at any given time 
(Brenner et al., 1988; Sweeney & Stull, 1990). Similar to Ca2+ regulated activation of the 
thin filament, RLC phosphorylation does not alter the rate of transition of crossbridges 
out of the force generating state (gapp). With this in mind, we assumed structural changes 
to the RLC, resulting from the CS, were the cause of the enhanced force, work and power 
of WT muscles over skMLCK-/-.    
5.2   RLC Phosphorylation 
 The experimental design was consistent with previous work from our lab that 
utilized a high frequency (100 Hz for 400ms) tetanic conditioning stimulus (CS) repeated 
four times within 10 s to enhance RLC phosphorylation (Gittings et al., 2012; Caterini et 
al., 2011). In the present study, the CS increased concentric force of WT muscles in all 
conditions concurrent with an almost 8 fold increase in phosphorylation above resting 
levels (0.08 and 0.63 mol Phos/mol RLC, respectively). In skMLCK-/- muscles, no 
difference was evident between rest and after activation by the CS (0.03 and 0.08 mol 
Phos/mol RLC, respectively). These results are in confirmation of the effects of 
stimulation in WT and skMLCK-/- muscles (Bunda et al., 2015; Gittings et al., 2011; 
2012; Zhi et al., 2005), however, our results display lower skMLCK-/- resting values for 
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phosphorylation than those reported above. For example, work by Gittings et al. (2012) in 
our lab reported no change in values (8-8) mol Phos/mol RLC for resting and stimulated 
conditions in skMLCK-/- muscles, respectively. These differences may suggest a 
discrepancy in our sample preparation of individual muscle homogenates, antibody 
incubation, or blot exposure time.  
 The residual phosphorylation levels in skMLCK-/- muscles have been suggested to 
be due to the activity of a non-specific kinase that does not change activity with 
stimulation (Zhi et al., 2005). Therefore, the concentric force potentiation observed in 
these mice indicates an alternate source of crossbridge formation i.e., increased 
myoplasmic [Ca2+resting], previously reported by Smith et al. (2013; 2014). 
5.3   Shortening Speed Dependence 
 The potentiation of concentric force is known to be shortening speed dependent, 
such that potentiation increases with shortening speed (Abbate et al., 2000; Caterini et al., 
2011; Gittings et al., 2012; Grange et al., 1998). The current study has extended this 
finding to include a shortening speed dependence of skMLCK-/- mice, a finding that is 
consistent with recent work within our lab (Gittings, Bunda, & Vandenboom, 2015: 
Abstract).  
 Contrary to results from Gittings et al. 2012, the present study observed the 
potentiation of concentric force at every shortening speed in WT muscles. Although the 
reason for this discrepancy is unknown, differences in experimental parameters such as 
shortening ramp length and activation duration may have contributed to this finding. In 
lieu of this, we agree with the findings of MacIntosh & Willis (2000) and the suggestion 
of Vandenboom et al. (2013) that stimulus duration may be a limiting factor for 
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determining the ability of potentiation to increase peak force. The rate of force 
development as showed in Table 2 +dF/dt shows an apparent increase in WT and 
skMLCK-/- muscles under all conditions.  
 A reduction in post-tetanic force at low speeds in skMLCK-/- but not WT muscles 
was observed, suggesting that RLC phosphorylation may mask the presence of fatigue 
caused by tetanic stimulation (Grange et al., 1998). However, at shortening speeds 0.20 
Vmax and above, remnant potentiation was still displayed in skMLCK-/- muscles; 
consistent with previous findings (Gittings et al., 2011; Gittings et al., 2014; Zhi et al., 
2005) implying a secondary mechanism is present in these mice. This mechanism is 
believed to be the result of an increase in resting myoplasmic [Ca2+] due to previous 
stimulation (Smith et al., 2013). Subsequently, Ca2+ buffers such as parvalbumin become 
saturated enabling a larger portion of free myoplasmic Ca2+ to bind Troponin C and 
increase force production (MacIntosh & Gardiner, 1989). 
5.4   Crossbridge Kinetics   
 It is known that crossbridge kinetics can be altered by several negative (H+, Pi, 
and pH) and positive (RLC-P, increased sarcomere lengths) effectors that determine the 
Ca2+ sensitivity of force generation (MacIntosh et al., 2003). Our results suggest that 
RLC phosphorylation acted as a positive contributor to Ca2+ sensitivity by increasing the 
rate of force development in WT muscles post-CS, which in turn enhanced the peak force 
of each submaximal contraction, with no distinguishable effect for shortening velocity. 
As figure 13 displays, similar to the observed effects of PTP on concentric force, the 
relative change in rate of force development was attenuated in skMLCK-/- (1.14) 
compared with WT muscles (1.25), when collapsed for shortening velocity. This 
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difference is consistent with previous work investigating skMLCK-/- mice (Gittings et al., 
2011) as well as work examining the effects of RLC phosphorylation on crossbridge 
dynamics (Metzger et al., 1989; Sweeney & Stull, 1990; Sweeney et al., 1993). 
Moreover, increases in +dF/dt in mouse lumbricals, a fast muscle without RLC 
phosphorylation, suggests theses changes are not selective to RLC phosphorylation. 
Therefore, the finding that skMLCK-/- muscles had a smaller yet still increased rate of 
force development, and peak force post-CS, illustrates that these mechanisms may be 
additive and/ or complimentary to each other. Indeed, when assessed as a whole, 
potentiation seems to provide a balanced system that effectively optimizes muscle 
performance.  
 The kinetics of -dF/dt exhibited a more complex speed dependent effect on 
contractile measures than did +dF/dt. For instance, in both genotypes the relative rate of 
relaxation was increased above Pre-CS values during slow shortening velocities (0.05- 
0.20 Vmax), reaching an almost 2 fold increase above Pre-CS at 0.20 Vmax (1.90 ± 0.11 & 
1.83 ± 0.12) in WT and skMLCK-/-, respectively. -dF/dt then slowed substantially until 
0.45 Vmax where it was similar to resting values between 0.45-0.65 Vmax, (p > .05). The 
results for WT may therefore be partly be explained by the findings of Patel et al. (1998) 
who suggested that RLC phosphorylation eliminates force-dependent effects of relaxation 
in permeabilized rabbit psoas fibers.  Contrarily, however, we did not observe any 
decrease in -dF/dt between genotypes, a result consistent with more recent findings using 
whole intact skeletal muscle (Gittings et al., 2014). This further indicates that force 
potentiation resulting from phosphorylation independent mechanisms i.e., increased 
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myoplasmic [Ca2+resting], alter the mechanical output of the contractile unit similar to RLC 
phosphorylation.  
5.5   Modulation of Peak Mechanical Function 
 We did not observe a significant rightward shift in optimal velocity for peak 
power. This may indicate a stimulus frequency threshold for this phenomenon. However, 
it is also important to note that this outcome may have resulted from our selection of 
experimental conditions, i.e., temperature, muscle, species, etc. For example, Abbate et 
al. (2000) observed that tetanic stimulation tended to cause a rightward shift in the 
velocity at which peak power occurred during brief high-frequency contractions. This 
suggests that modulation of peak power is not limited to an upward shift in power output; 
but rather, power may also peak at a higher shortening velocity when significant 
potentiation impacts force production. However, these experiments were conducted using 
rat gastrocnemius muscle (35oC; at 80 Hz), and therefore, the effects of potentiation are 
subject to change (Vandenboom et al., 2013). Considering that potentiation decreases 
with increases in stimulation frequency (Brown & Loeb, 1998; MacIntosh et al., 2008), 
lower stimulation frequencies (< 100 Hz) may be necessary to induce the shift in velocity 
for the attainment of peak power. Nonetheless, the tetanic CS resulted in a substantial 
relative increase in power output across shortening velocities (1.28 and 1.12), in WT and 
skMLCK-/- muscles, respectively. Our results indicate that RLC phosphorylation is 
responsible for roughly half of the concentric potentiation of power output across a wide 
range of shortening velocities. Therefore, without the skMLCK enzyme, optimal muscle 
performance is impeded. 
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5.6   In Vivo Applications 
 A brief but intense warm up before exercise or sport, that activates fast-twitch 
muscle fibers, may be ‘prepping’ the body for inducing an optimal level of potentiation 
(Brown & Loeb, 1998). Furthermore, a prolongation of potentiation as a result of 
hormonal input from adrenaline may serve a role in the fight or flight response (Decostre, 
Gillis, & Gailly, 2000). The augmentation of peak power largely by phosphorylation of 
the RLC will surely add to this biochemical ensemble that seems to function to create 
optimal mechanical performance. As previously suggested by Grange et al. (1998) and 
Abatte et al. (2000) an increase in power output during potentiation may be advantageous 
for several reasons: 1) The muscle will yield greater work and power for a given level of 
neural activation 2) a mechanical or biochemical feedback loop that decreases motor unit 
firing rate may permit maintenance of work and power during sustained rapid 
movements; an effect that may reduce fatigue 3) fewer activating pulses needed for 
power output will consequently reduce the amount of Ca2+ needing to be sequestered by 
the SR, preserving ATP, and in turn preventing fatigue.  
 High frequency pulses  (>80 Hz) followed by a train of lower frequency pulses 
e.g., 30 Hz has been previously shown to increase force, work and power of both 
isometric and concentric contractions (Abbate et al., 2002; Binder-Macleod & Kesar, 
2005). Interestingly, the augmented force responses have been attributed to enhanced 
Ca2+ sensitivity and cooperativity irrespective of RLC phosphorylation content (Abbate et 
al., 2002). This may implicate the role of high frequency pulses at the onset of 
contraction for increasing transient performance, while the steady increase in RLC 
  82 
phosphorylation over time may decrease the impact of fatigue (Gittings et al., 2011; 
Rassier & Macintosh, 2000).  
 Although our results led us to conclude that no increase in velocity was found for 
peak power, recent findings characterizing motor unit behavior in mouse LG muscles 
(lateral gastrocnemius) reveal that sedentary activation occurs within the range of 9-68 
Hz (Ritter, Tresch, Heckman, Manuel, & Tysseling, 2014). During active movements it is 
assumed that fast-fatiguable motor units will be recruited at higher firing rates that may 
reach 100 Hz or higher. Therefore, our chosen activation frequency may rival the 
activation of fast-fastiguable motor units in vivo. With this in mind, we conclude that a 
rightward shift in the optimal velocity for peak power may be selective to experimental 
conditions that optimize potentiation; but that do not mimic realistic in vivo settings.  
5.7   High Velocity for Peak Power  
 Mouse gait patterns are resoundingly similar to human patterns as they exhibit a 
walking phase, a trot/jog phase, and a gallop/run phase. The gallop is most relevant to 
potentiation since fast glycolytic fibres become increasingly important as speed increases 
during locomotion (Armstrong et al., 1977). Galloping requires muscles to shorten over a 
longer distance causing the muscle to shorten faster in order to provide smooth rhythmic 
motion. Consistent with this, The EDL has been shown to shorten between 0.37-0.52 
Vmax during the gallop phase of locomotion (James, 1995). Thus, peak power output at 
shortening velocities of ~ 0.50-0.55 Vmax, as observed in our study using curve fitting, 
may represent the physiological peak of mechanical functioning during shortening in 
vivo. Although original power calculations based on the Hill model indicated power to 
fall around 0.30 Vmax or 0.30 Fmax, the model also assumed muscles would naturally 
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operate at an optimal power that corresponded to operating frequency (Hz) i.e., 30 Hz at 
0.30 Vmax. As pointed out by Josephson, (1993) some muscles may operate at a lower or 
higher percentage of force and velocity depending on their internal characteristics and 
roles within the body. As such, a muscle such as the EDL with a high content of fast-
fatigable (2b) fibers will undoubtedly have a higher peak power output. 
 Several experimental parameters may have also lead to the culmination of a very 
rapid V/Vmax value for peak power. For example, the shortening ramp employed was used 
to replicate mouse locomotion by minimizing the amplitude of length change of the EDL 
i.e., 1.05-0.90 Lo (Marsh, 1999). This also deterred changes in the passive elements from 
altering force and augmenting potentiation (Abbate et al., 2002); however, the use of 
small length changes may have contributed to the muscles ability to maintain high power 
output at high speeds. In addition to this, using two pulses for each shortening ramp may 
have elevated peak power output since fast shortening (0.45-0.65 Vmax) resulted in force 
production across the entire shortening ramp; unlike slow shortening (0.05-0.035 Vmax), 
where force production had ceased long before shortening had finished. We therefore 
speculate that length dependent increases in potentiation augmented fast speeds of 
shortening at the shortest relative muscle lengths (0.95-0.90 Lo) or increased cooperative 
interactions may have assisted crossbridge binding (Dickenson et al., 1997). Furthermore, 
the potentiation of force may have been enhanced during fast shortening by sensitizing 
the contractile apparatus to RLC phosphorylation, via thin filament deactivation, or 
increases in Gapp (ADP detachment) at high percentages of Vmax (Gittings et al., 2012; 
Piazessi et al., 2007; Stull et al., 2011). 
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 Altogether, any effects that may normally impair force transmission: shortening 
deactivation, sarcomeric uniformities etc., are less likely to alter force production under 
these force-enhancing conditions. 
5.8   Reductions in Power With Aging 
 Age related differences in force and velocity properties exist between adult and 
elderly mouse EDL muscles. These differences are most notably observed by a reduction 
in power output in elderly mice (Brooks & Faulkner, 1988a, b; 1991). More recent work 
(Graber et al., 2015) has expanded this finding by observing a reduction in time to peak 
tension, power output and peak contractile velocity during shortening, coincident with a 
21 % decline in the fast-isoform of RLC (MLC3f) in elderly EDL muscles. Interestingly, 
these aged muscles displayed a downward and leftward shift in the force-velocity curve. 
This effect is the opposite of what we hypothesized would occur in young adult mice 
within the current study and would suggest a reduction in MLC3f and type 2b fiber 
content causes power loss and declining muscle performance with aging. As previously 
mentioned, there may be a frequency threshold for rightward shifts in force-velocity 
properties; however, consistent with previous studies (Abbate et al., 2000; Grange et al., 
1995; 1998) we did observe an upward shift in power output during potentiation. 
 Similar deleterious effects in power output are seen in patients with statin myalgia 
whom display an increased time to peak tension and blunting of power output during 
exercise (Mallinson et al., 2015). Further examination of the link between RLC 
phosphorylation, power output, and aging may elucidate its role in the prevention of 
power loss and muscle weakening associated with sarcopenia and other diseases. 
Moreover, resistance training programs for older adults may need to include power 
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movements at high-load to deter the loss of type 2 motor units and underlying changes to 
skeletal muscle isoforms e.g. RLC3f. 
5.9   Significance  
   
 The enhancement of power output across an array of physiological shortening 
speeds, as observed in our study, may result in several benefits for locomotion. For a 
muscle such as the EDL that is activated, and under strain, largely while the lower limb is 
in flight, potentiation may positively impact shortening velocity. For example, when 
running speed increases, the limbs must increase stride length, therefore, shortening 
velocity must increase while maintaining power output.  
 Our results show that when power output is collapsed across shortening velocities, 
the presence of RLC phosphorylation in muscles stimulated with a tetanus (WT), 
increases power output to 1.28 ± 0.05 compared with 1.11 ± 0.05 in stimulated muscles 
absent of stimulation induced RLC phosphorylation (skMLCK-/-). By comparing these 
values our study was able to demonstrate that RLC phosphorylation contributed 60 % of 
the overall effect of PTP on power output. With this in mind, modeling of locomotion 
should be careful to interpret data of both un-stimulated and stimulated skeletal muscles.  
Adopting both resting and activated fast-twitch skeletal muscle models to describe the 
force-velocity relationship will better represent the functional properties of skeletal 
muscles in vivo. The force-velocity properties of skeletal muscles under resting 
conditions dictates that the force per crossbridge during fast shortening will decrease due 
to more rapid ADP release, leading to faster cycling as the myosin motor translates force 
into filament sliding (Piazessi et al., 2007). However, when fast fibers are activated, RLC 
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phosphorylation, as well as stimulation induced alterations to myoplasmic [Ca2+resting], 
may deter force loss by increasing the attachment rate of cycling crossbridges (Fapp) 
(Sweeney & Stull, 1990). Perhaps the most convincing statement supporting the need for 
this change is that of Brown and Loeb, (1998): “Potentiation may be the working state of 
fast-twitch skeletal muscle”. In sum, without potentiation, and without signaling to 
trigger RLC phosphorylation, muscle performance and movement is diminished.  
 
5.10   Limitations 
 The stimulation paradigm used in our study was intended to simulate brief high 
frequency contractile events previously reported to occur at the onset of locomotion 
(Binder-Macleod & Kesar, 2005; Garland & Griffin, 1999; Henig & Lomo, 1985). 
Although we hypothesized this form of activation is physiologically relevant, especially 
in regards to the EDL muscle, a longer train of lower frequency stimulation may have 
been more effective in attaining high levels of potentiation and mimicking sustained 
locomotor movements. However, it should be noted that the purpose of this study was to 
examine a brief near maximal stimulus/ contraction paradigm to determine peak power; 
long duration, repeated contractions would have increased fatigue and masked the 
contribution of potentiation to power output.  
 The range of shortening velocities used proved to be insufficient in creating 
adequate power velocity curves for the assessment of peak power. Higher shortening 
velocities may be needed to achieve a better understanding of modulations to force and 
velocity properties after repetitive stimulation. 
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5.11   Summary 
 Our results were consistent with previous work demonstrating potentiation in the 
range of what is considered to be physiologically applicable to ‘in vivo’ stimulation 
frequencies and length/ speed changes (Abbate et al. 2000; Gittings et al. 2012; 
MacIntosh, Taub, Dormer, & Tomaras, 2008; MacIntosh & Bryan, 2002). The increases 
in work and power can be attributed to an increased rate of crossbridge attachment (fapp) 
and changes in kinetics such as the increased +dF/dt. After collapsing across shortening 
velocities tetanic stimulation elevated concentric force in skMLCK-/- mice to 1.11 ± 0.05 
compared with 1.28 ± 0.05 in WT muscles. The present results thus confirm the genotype 
dependence (Gittings et al., 2014) of concentric force potentiation. By subtracting 
skMLCK-/- values from WT the portion of power enhancement credited to RLC 
phosphorylation compared with phosphorylation-independent potentiation was found to 
be ~61 % across velocities and ~41 % for peak power. This implicates RLC 
phosphorylation as a major contributor to enhanced power after stimulation. The finding 
of a high optimal velocity for peak power (~0.50-0.55 Vmax) in EDL suggests that muscle 
fiber type composition, as well as the role of the muscle within the body, may lead to 
different relative peak powers than expected by the Hill equation. 
 The reduction in force as velocity of shortening increases occurs due to rapid 
dissociation of myosin from actin, an effect that reduces the population of attached 
crossbridges. The reduced number of strongly bound crossbridges in turn is associated 
with reduced Ca2+ occupancy of TnC (Vandenboom, Claflin, & Julian, 1998). However, 
RLC phosphorylation minimizes reductions in crossbridge attachment, displaying the 
  88 
largest effect during rapid shortening (0.45-0.65 Vmax) when thin filament activation is 
low.  
  
5.12   Future directions 
 The current study did not observe a rightward shift in velocity for the attainment 
of peak power. More research is needed to examine the effects of low activation 
frequencies on peak power of skeletal muscle. This is supported by larger increases in 
potentiation seen at lower compared with higher frequencies (Gittings et al., 2012). 
Furthermore, a more pronounced deviation in contractile kinetics may emerge between 
genotypes, at lower frequencies, creating a shift in peak power.  
 Treadmill gait analysis in rodent models may illuminate locomotor limitations to 
the skMLCK gene ablation in vivo. Previous investigations have already greatly enhanced 
the ability to infer changes in gait parameters during walking, trotting, and galloping rats 
and mice (Clarke & Still, 1999; 2001; Herbin, Hackert, Gasc, & Renous, 2007). Thus, 
comparison of WT with skMLCK-/- mice will determine if any overt physical differences 
in performance exist stemming from RLC phosphorylation.   
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 Appendix A: Compilation of Studies Examining Potentiation 
Table 9. Experimental data of potentiation in whole-isolated skeletal muscle of various animal 
models (Vandenboom et al., 2013). 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
function will be modified to account for these results. The
genetic, enzymatic and regulatory aspects of RLC phos-
phorylation have been recently reviewed by Stull et al.
(2011) and will not be detailed in this article.
First described in the literature over 100 years ago (see
Lee 1907) force potentiation has long been recognized as a
fundamental property of fast twitch skeletal muscle.
Potentiation is generally expressed as an increase in iso-
metric twitch force independent of change to peak tetanic
force, thus increasing the twitch to tetanus ratio (e.g., Ba-
gust et al. 1974; Ramsey and Street 1941). In contrast, slow
twitch skeletal muscle displays a posttetanic depression of
isometric twitch force (Buller et al. 1981; Close and Hoh
1969). A list of studies describing potentiation of fast
twitch vertebrate striated muscle is compiled in Table 1.
Potentiation is readily induced in most fast twitch skeletal
muscles studied and as such may be a normal operating
feature of these muscles (Brown and Loeb 1998). In the
Table 1 Potentiation in isolated skeletal muscles in which RLC phosphorylation was not measured
Authors Species Muscle Temp Rate and duration Main findings
Abbate et al. (2000) Rat MG 34 160 Hz, 1 s Concentric power : at 80–120 Hz
Bagust et al. (1974) Cat FDL, sol NR 100 Hz, 300 ms PTP ; as time to peak tension :
Brown and Loeb (1998) Cat CF 37 Various high freq Pt:Po : five fold
Brown and Loeb (1999) Cat CF 37 Various high freq PTP ; as muscle length :
Brown and von Euler (1938) Cat Gastroc, sol,
TA
37 High frequency, 2–20 s Stimulus duration dependence for PTP
Buller et al. (1981) Cat Sol 37 100 Hz, 300–1,000 ms ; Pt:Po with : stim number
Close and Hoh (1968a) Rat EDL, sol 20–35 Repetitive stimulation EDL, PTP : with temp; sol, no PTP
Close and Hoh (1968b) Rat EDL 35 20 and 300 Hz; various PTP varies with pulse # at each frequency
Close and Hoh (1969) Rat EDL, sol 35 200 Hz, 1 s Cross-innervation: PTP : sol, ; EDL
Grange et al. (1998) Mouse EDL 25 5 Hz, 20 s Work loop area : 25–30 % by PTP
Guttman et al. (1937) Frog Gastroc NR 10–30 Hz, 1–20 s PTP coexists with fatigue
Krarup (1981a) Rat EDL 37–38 2–5 Hz; 125–167 Hz Biphasic effects of duration and stimuli #
Krarup (1981b) Rat EDL 20–38 5 Hz, 50 s SP : as temp :
Krarup (1981c) Rat EDL 37–38 5 Hz, 50 s; 167 Hz, 1.5 s Dantrolene : SP and PTP
Krarup (1983) Rat EDL 37–38 3–10 Hz, 1.5–3 s Potentiation ; in myasthenia gravis
MacIntosh and Gardiner
(1987)
Rat Gastroc 37 200 Hz, 1 s Fat x caff : PTP additively
MacIntosh and Willis (2000) Rat Gastroc 37 2–5 pulses at 20–80 Hz PTP ; as force approaches Po
MacIntosh et al. (1988) Rat Gastroca 37 10 Hz, 15 s TTX ; SP by *75 %
MacIntosh et al. (2008b) Rat Gastroc 37 200–400 Hz (2–4 pulses) : Force, work and power at high
frequencies
Ramsey and Street (1941) Frog Single fibers 22 Tetani 5–180 s PTP : at low Pt:Po in isolated fibers
Rankin et al. (1988) Rat Sol, EDL 35–37 0.5 Hz 32 s; 100 Hz 500 ms : Pot in ; fatigable EDL muscle
Rassier and MacIntosh
(2002)
Mouse EDL 22–35 10 Hz 10 s; 75 Hz 1.5 s Pot ; long lengths at both temps
Rassier and MacIntosh
(2000)
Rat Gastroc 37 5 Hz, 20 s Dant ; Pot but not length dependence
Rassier et al. (1998) Rat Gastroc 37 10 Hz, 10 s Caff ; Pot and abolishes length
dependence
Rassier and Herzog (2002) Mouse EDL 25 10 Hz, 10 s ; pH abolishes length dependence
Standaert (1964) Cat Sol, gastroc 37 400 Hz 10 s (s);200 Hz 10 s
(g)
Fibre and motor unit dependence for PTP
Vergara et al. (1977) Frog Semitend 15 20 Hz, 5–200 s Long lasting PTP with fatigue
Studies examining staircase or PTP in which RLC phosphorylation was not measured arranged alphabetically by first author. Columns (left to
right) describe species, muscle(s) and experimental temperature (Temp) as well as the stimulation paradigm used to induce potentiation as
frequency in Hz and duration (in ms or sec) with a summary of main findings
CF caudofemoris, EDL extensor digitorum longus, FDL flexor digitorum longus, gastroc gastrocnemius, MG medial gastrocnemius, sol soleus,
semitend semitendinosus, TA tibialis anterior, caff caffeine, Dant dantrolene, # number, Po peak tetanic force, Pt peak twitch force, pot
potentiation, SP staircase potentiation, TTX tetrodotoxin. (NR not reported). Note that due to space constraint not all studies could be included
a Tetrodotoxin muscle model used
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Table 10. Experimental data of potentiation in whole-isolated skeletal muscle of various animal 
models in which RLC content was measured (Vandenboom et al., 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  these interactions to displace myosin heads away from the
thick filament (Alamo et al. 2008; Brito et al. 2011; Craig
et al. 1987; Hidalgo et al. 2001; Levine et al. 1991, 1996,
1998; Padro´n et al. 1991; Ritz-Gold et al. 1980; Sweeney
et al. 1994; Yang et al. 1998). It is proposed that these
phosphorylation-induced changes to myosin head position
on the thick filament surface increase the Ca2? sensitivity
of force development by promoting the formation of the
actomyosin complex achieved by Ca2? signalling alone
(see below). These structure–function relations are con-
sistent with findings from intact rat skeletal muscle show-
ing that potentiation is greatest at short and minimized at
long sarcomere lengths, respectively (e.g., Rassier et al.
1997, 1998; Rassier and MacIntosh 2000) (c.f. Moore and
Persechini 1990). Finally, findings from experiments using
in vitro motility assays showing that phosphorylation of the
RLC does not improve intrinsic myosin motor function in
isolation from the thin filament supports these arguments
(Greenberg et al. 2009).
RLC phosphorylation and cross-bridge cycling kinetics
Huxley (1957) was the first to provide an analytical frame-
work for understanding cross-bridge cycling in skeletal
muscle. In his original scheme Huxley proposed that muscle
force was regulated by the cyclic attachment and detach-
ment of ‘‘side pieces’’ between the myofilaments. These rate
constants, known as F and G, respectively, were considered
intrinsic properties of independently operating force gen-
erators within the sarcomere; these structures were, in time,
recognized as the actomyosin cross-bridge. Brenner and
Eisenberg (1986) and Brenner (1988) advanced this two
state model for cross-bridge action by incorporating the
regulatory influence of Ca2? binding to troponin C (TnC) on
force. In their modern scheme, Ca2? binding to TnC con-
trols the rate constant describing the transition of cycling
cross-bridges from non-force to force generating states (i.e.
fapp). In contrast, the reverse rate constant describing the
transition of cycling cross-bridges from force generating
Table 2 Potentiation in isolated rat and rabbit skeletal muscle in which RLC phosphorylation was measured
Author(s) Species Muscle Temp Rate and duration % RLC-P Main findings
Abbate et al. (2001) Rat MG 34 160 Hz, 1 s 13–42–50 PTP ; economy of contraction
Barsotti and Butler (1984) Rat EDL 23 66 and 100 Hz,
1–10 s
5–73 RLC-P does not alter energy usage
Klug et al. (1982) Rat Gastroc 37 5 Hz, 5–20 s 19–63 PTP correlated with RLC-P
MacIntosh and Bryan
(2002)
Rat MG 37 80 Hz, 4–7 s 11–33–50 : Isotonic work (shortening)
MacIntosh et al. (2008a)a Rat Gastroc 37 5 Hz 21 s;
200 Hz 1–10 s
15–42
11–9a
SP without RLC-P
MacIntosh et al. (1993) Rat Gastroc 37 10 Hz 20 s 10–72; 3–19 Fatigue ; RLC-P
Manning and Stull (1982) Rat EDL sol 23–35 10–200 Hz 14–60 FT and temp dep for RLC-P and
PTP
Manning and Stull (1979) Rat EDL 23 200 Hz, 1 s 10–75 PTP and RLC-P correlated
Moore and Stull (1984) Rat Sol, gastroc 37 1–100 Hz, 10 s 0–34 s;
10–62 g
PTP & skMLCK activity ; with :
OP
Moore et al. (1985) Rabbit Sol, plan 38 100 Hz, 15 s (s)
5 Hz, 20 s (p)
2–10 s;17–45 p No PTP (sol); 58 % PTP (plan)
Rassier et al. (1999) Rat Gastroc,
plan
37 10 Hz, 10 s 5–26 SP w/o : RLC-P
Rassier et al. (1997) Rat Gastroc 37 10 Hz, 10 s 10–15; 35–40 Len Dep of SP not RLC-P
dependent
Tubman et al. (1996a) Rat Gastroc 37 200 Hz, 0.5–2 s 55 c; 40 f Fatigue ; RLC-P but not PTP
Tubman et al. (1996b)b Rat Gastroc 37 10 Hz, 10 s 5–9b; 21–57 No PTP and no RLC-P with atrophy
Tubman et al. (1997)a Rat Gastroc 37 200 Hz, 2 s 5–21a; 14–49 PTP and RLC-P ; with atrophy
Studies examining staircase or PTP in rat and rabbit muscles in which RLC phosphorylation was determined, arranged alphabetically by first
author. Columns (left to right) describe species, muscle(s) experimental temperature (Temp), stimulation paradigm used to induce potentiation
(as frequency in Hz and duration in ms or sec), the range (minimum and maximum) of RLC phosphorylation (as %) reported at rest and in
response to stimulation and a summary of main findings
EDL extensor digitorum longus, gastroc gastrocnemius, GM medial gastrocnemius plan plantaris, sol soleus, FT fiber type, len dep length
dependence, OP oxidative potential, PTP posttetanic potentiation, skMLCK skeletal myosin light chain kinase, SP staircase potentiation, temp
dep temperature dependence
a Hemisection muscle model used; b tetrodotoxin muscle model used
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Table 11. Experimental design for collection of contractile data during pilot experiments. The 
table shows the different pairings of shortening ramps from the beginning of an experiment to the 
end (left to right) between muscle samples. 
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Figure 23. Mean concentric active force traces for each shortening speed, genotype, and condition 
(pre and post-CS). a) Represents mean force produced by WT muscle at rest (pre-CS); b) 
represents WT response after stimulation (post-CS); c) represents skMLCK-/-response at rest (pre-
CS); d) represents skMLCK-/- response after stimulation (post-CS). 
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Figure 24. Raw concentric force traces during shortening ramps at 0.05 (A, C) and 0.70 Vmax (B, 
D) in WT (upper panels) and skMLCK-/- (lower panels) mouse EDL muscle (n = 1), before (solid 
line) and after (dashed line) a tetanic conditioning stimulus.  Length change (1.05-0.90 Lo) is 
superimposed to signify complete relaxation from force before the end of shortening. 
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Figure 25. Representative traces of mean force (A) and length (B) during high frequency 
activation (100 Hz). Traces are taken from pre-CS WT muscle only (n = 1).  
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Appendix C: Western Blotting 
Measurement of Myosin Regulatory Light Chain Phosphorylation by UREA/Glycerol-
PAGE with Immunoblotting 
 
Background 
 Myosin Regulatory Light Chains (RLCs) are small 18-20kDa) acidic proteins that 
are essential in the conversion of chemical energy into kinetic movement. RLCs migrate 
easily in polyacrylamide gels containing glycerol for increased density. RLCs are 
denatured with Trichloracetic acid (TCA) and solubilized in urea to dissociate from their 
larger myosin heavy chain counterpart. The addition of a phosphate group introduces two 
additional negative charges at a pH of 8.6 (the pH of the running buffer) so the 
phosphorylation measurements are in fact quantitative (mol of phosphate per mol RLC) 
after measurement of the protein band density by Immunoblotting. 
  
 The following protocol is an adaptation of the work by Dr. James Stull of the 
University of Texas Southwestern Medical Centre. 
 
Sample Preparation 
1. Freeze tissue samples (quickly with pre-cooled tongs) in liquid nitrogen and store at -
80oC (big freezer).  
2. Add 0.5mL 10% of Tricholoracetic Acid (TCA; stock is 100% concentrated solid)/ 
10mM dithiothreitol (DTT) in acetone to individual polypropylene tubes and freeze 
in liquid nitrogen. 
  118 
3. Tubes are to be placed in -20oC cold box (mini fridge), measure weight of frozen 
muscle tissue in cold box and then place muscle in the tube on top of the mixture 
from Step 2.  
4. Submerge the muscle into the slurry.  
 N.B. The frozen TCA and DTT in acetone solution will thaw and form a slurry at -
35oC. 
5. Remove tubes from cold box and allow them to reach room temperature. 
6. Transfer each denatured muscle sample to a ground glass homogenizing tube and add 
0.5mL 10%TCA/ 10mM DTT in H2O.  
 N.B. The glass tubes to be used are Wheaton USA Ground Glass Tissue Grinders 
(3mL) 
7. After complete homogenization, transfer homogenate to an Eppendorf tube. 
8. Allow the homogenate to sit on ice for 10 minutes or more.  
9. Centrifuge the samples at 2000 RPM for 3 minutes at room temperature on tabletop 
centrifuge.  
 N.B. Do not pack the protein too hard or too long because it will become difficult to 
separate.  
10. Carefully decant the supernatant fraction via pouring.  
11. Wash protein (now a soft pellet) with 500µL of ether 3 times for 5 minutes each to 
remove any residue left by TCA (in total 15 minutes of washing).  
12. Ether will evaporate from tube under fume hood and let this occur for 5 minutes. 
 N.B. If the protein pellet is left in the hood, it will dry out completely  
13.  Add 30 µL of urea sample buffer per mg of frozen tissue weight (Appendix I).  
14. Vortex each sample vigorously for 1-2 minutes.   
 N.B. This causes the protein pellet to disperse; you should not have to manually 
disperse the protein pellet.  
15.  Check to ensure pH has a value of 9 and confirm this by the blue colour of the 
sample. 
 N.B. If the colour is yellow or green, add 5 µL of 2 M Tris Base (basic; pH of 11) 
16. Add a few crystals of urea and vortex. Urea may dissolve completely and if it does 
add more crystals until samples are saturated.  
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18. Store at -80oC if not running gel the same day. 
N.B. This process is crucial and may take 1-2 hours ensuring all RLC is solubilized. 
DO NOT heat urea samples on thawing because carbamylation can change the 
protein’s charge. Mix about 1 hour after thawing in water bath. 
 
 
Preparing Glycerol Gels 
1. Mix Appendix II and stir for 10 minutes under vacuum. 
2. Add 107 µL of 10% APS and 17 µL of TEMED and mix by swirling.  
3. Pour quickly into prepared mini-gel apparatus and insert 10 well combs 
N.B. No Stacking Gel. Gel should polymerize after 40 minutes. 
 
Running Buffer 
1. Lower Buffer: 83mL of Urea Gel Buffer † / 917mL of H2O 
2. Upper Buffer: 73.3mg DTT/ 53.3 mg thioglycholate/ 200mL of Lower Buffer 
3. Urea Gel Buffer † 
 
Pre- Electrophoresis 
1. Rinse with H2O to remove any debris.  
2. Rinse wells with Upper Buffer (73.3mg DTT/ 53.3 mg thioglycholate/ 200mL of 
Lower Buffer). 
3. Assemble apparatus and pre-electrophorese @ 400V for about 1 hour to get 
thioglycholate into gel to reduce any residual APS and prevent protein oxidation. 
 
Electrophoresis 
1. Load 5-20 µL of each sample; since there is no stacking gel the tip of the pipet 
should be close to the well of the gel and added slowly with sample in the urea 
sample buffer. 
 N.B. The layer should be a sharp band.  
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2. Load 15 µL to get good protein bands, if protein is to concentrated, sample can be 
diluted with urea sample buffer 
 N.B. Do not include end wells as they tend to distort.  
3. Electrophorese @ 400V for 85 minutes 
 
 
 
Membrane Transfer 
A. Nitrocellulose  
1. Cut off approx. ¼ of the upper part of gel.  
2. Rinse gels gently in transfer buffer for 5 minutes each. 
3. Immerse nitrocellulose membrane in transfer buffer for 1 minute to wet it. 
**How the sponge, blotting paper, nitrocellulose or PVDF and gel should be organized.  
 
      Sponge layer (cathode side -) 
       
      Filter Paper      
    
      Nitrocellulose/ PVDF membrane 
       
      Gel 
     
      Filter Paper 
     
      Sponge layer (anode side +) 
 
4. Transfer membrane @ 25V for 1 hour. 
See Appendix III for Transfer Buffer and Appendix IV for 10x Transfer Buffer. 
 
B. PVDF 
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1. Pre- soak membrane in methanol for 5 minutes.  
2. Cut off approx. ¼ of the upper part of gel.  
3. Rinse gels gently in transfer buffer for 5 minutes each. 
4. Immerse PVDF membrane in transfer buffer for 1 minute to wet it. 
N.B. PVDF is done the same as nitrocellulose except it is presoaked in methanol for 5 
minutes. 
 
Membrane Preparation after Transfer 
A. Nitrocellulose 
1. Wash the membrane in TBST 3 times for 10 minutes each. 
N.B. See Appendix V for TBST 
2. Block with blocking buffer for 1 hour at room temperature to prevent non-specific 
binding. 
N.B. See Appendix VI for Blocking Buffer 
3. Add between 1:7500 skRLC polyclonal antibodies to blocking buffer and incubate 
with rocking overnight at 4oC [1.333 µL skRLC/ 10ml blocking buffer]. 
B. PVDF  
1. Soak membrane in 0.4 glutaraldehyde in PBS ifor 30 minutes room temperature. 
2. Wash membrane 3 times in PBS.  
3. Block with 5% Amersham blocking solution for 1 hour. 
4. Add 1o antibody in 0.5% blocking solution for 1 hour at room temp with gentle 
shaking, rocking, or rolling. 
 
Membrane Treatment 
**IDENTICAL STEPS EXCEPT TBST AND PBS  
A. Nitrocellulose 
1. Remove primary antibody (buffer can be re-used up 3 times) and wash membrane 
with TBST 3 times for 10 minutes each.  
2. Incubate the membrane with 2o (1:10000) goat anti-rabbit IgG- HRP in TBST for 1 
hour @ room temperature. 
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3. Wash membrane 3x for 10 min each time with TBST.  
4. Make detection buffer (ECL Plus).  
a. Mix equal volumes of luminol reagent and oxidizing agent i.e., 3ml & 3ml.   
5. Incubate the membrane in detection buffer for 3-5 minutes.  
6. Drain excess reagent, rinse with dH2O, and cover with plastic blot protector.  
  
B. PVDF 
1. Remove primary antibody (buffer can be used up 3 times) and wash membrane with 
PBS 3 times for 10 minutes each.  
2. Incubate the membrane in 1:10000 goat anti-rabbit IgG- HRP in PBS for 1 hr @ 
room temperature. 
3. Wash membrane 3x for 10 min each time with TBST.  
4. Make detection buffer (ECL Plus).  
a. Mix equal volumes of luminol reagent and oxidizing agent.  
5. Incubate the membrane in detection buffer for 2 minutes.  
6. Drain excess reagent and cover with plastic wrap. 
 
Development (Enhanced Chemiluminescence) 
1. Using FlourChem 5500 (Alpha Innotech), select “INSERT” function on the 
computer and wait for instrument to initialize. 
2. Open main door and place your sample on the glass, aligning numbers and letters on 
the side of glass. 
3. Move sample to fit current camera location and make sure membrane is placed 
protein side down; cover the back with parafilm:  
Click Chemiluminescence  
4. Add appropriate exposure time (may vary) to ensure complete image transfer. 
5. Click on the Scan icon, and a save option will pop up 
6. Save file as name, date and experiment, under Save Scan Data In option and 
specify location where you want saved (use a USB or save to desktop using a 
separate folder) 
7. Then click Save to continue 
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8. Analyze later using blot software “Imagej” or “Image Studio Lite” by LI-COR.  
Particular Supplies and Reagents 
• Secondary antibody- goat anti rabiit IgG HRP  
• ECL plus Amersham 
• Homogenizing tubes: Wheaton USA Ground Glass Tissue Grinders, 3mL (mortar 
and pestle) 
• Nitrocellulose mem, 0.45 micrometre pore size from Bio- Rad 
• PVDF membrane, 0.45 micrometre pore size for Immobilon-P membrane from 
Milipore 
 
Typical Results 
• Different phosphorylated forms of the skRLC are separated in this gel system; 
nonphosphorylated RLC, mono- (Mono-P RLC), and di- (Di-P RLC) 
 
                                                
 
APPENDIX I 
 
Sample Buffer 
REAGENTS QUANTITY 
8 M Urea 1.83 mL 
Urea Gel Buffer  167.0 µL 
0.5 M DTT 40.0 µL 
Saturated Sucrose 100.0 µL 
0.2% Bromophenol Blue 40.0 µL 
0.4 M EDTA 1.0 µL 
 
 
Urea Gel Buffer 
REAGENTS QUANTITY 
Trizma Base 13.7 g 
Glycine 10.0 g 
H2O Q.S. to 500ml 
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APPENDIX II 
 
 
Gel Casting Reagents 
REAGENTS QUANTITY 
Ammonium persulfate 0.10 g 
dH20 1.0 mL 
 
 
Urea/ Glycerol Gel Polyacrylamide Gels 
REAGENTS QUANTITY 
dH2O 4.2 mL 
Glycerol 9 mL 
30% Acrylamide/ Bis 29:1 7.5 mL 
Urea Gel Buffer† 1.9 mL 
Stir for 10 minutes under vacuum to degas 
10% APS ~113.0 µL 
TEMED ~20.0 µL 
Mix by swirling 
Quickly pour into minigel apparatus & insert combs 
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APPENDIX III 
 
 
 
Transfer Buffer 
REAGENTS QUANTITY 
10X Transfer Buffer 100 mL 
100% Methanol 200 mL 
dH2O 700 mL 
 
 
 
 
APPENDIX IV 
 
 
10x Transfer Buffer 
REAGENTS QUANTITY 
Glycine 144.12 g 
Tris  30.29 g 
SDS 5.0 g 
dH2O 500.0 mL 
Dissolve 
dH2O Q.S. to 1.0 L  
 
 
APPENDIX V 
 
 
10x TBS 
REAGENTS QUANTITY 
NaCl 87.66 g 
2M Tris pH 7.5 (HCL) 15.76 g 
10% Tween 30.0 mL 
dH2O Q.S. to 1.0 L 
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Tris-Buffered Saline with Tween-20 (TBST) 
REAGENTS QUANTITY 
10x TBS 100.0 ml 
Tween-20 0.50 mL 
dH2O Q.S. to 1.0 L 
 
 
 
 
 
APPENDIX VI 
 
 
Blocking Solution 
REAGENTS QUANTITY 
Carnation fat- free powdered milk 10.0 g 
TBST Q.S. to 200.0 ml 
 
 
